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Cytochrome P450 reductase (CPR) is an electron transporter enzyme that plays an 
essential role in xenobiotic transformations, including metabolism of carcinogens, 
environmental agents, and drugs.  CPR, a membrane bound flavoprotein, contains two 
flavin cofactors--flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN)--
each bound to a separate protein domain.  Both flavin cofactors utilize three distinct 
oxidation states:  oxidized (OX), semiquinone (SQ) (one electron reduced), and 
hydroquinone (HQ) (two electron reduced).  The multiple oxidation states of the flavin 
cofactors allow CPR to catalyze the essential transfer of electrons from the obligate two-
electron donor NADPH to the one-electron acceptor heme-iron of cytochrome P450. 
A comparison of the FMN-binding domains in various related flavoproteins reveals 
that the FMN binding loops differ in their size, conformations, and primary structure yet 
each contains a conserved glycine residue.  My research project was designed to evaluate 
the functional significance of this conserved glycine in rat CPR (Gly-141) through its 
replacement with threonine using site-directed mutagenesis. This replacement was made 
in both the intact reductase and the isolated FMN-binding domain (FBD).  Based on 
previous research on the flavodoxin, we hypothesized that the larger, beta-branched side 
chain of threonine would disrupt the hydrogen bond between residue 141’s carbonyl 
group and the N5H of the reduced flavin, which should destabilize the functionally 
relevant semiquinone state. 
Using a standard steady-state turnover activity assay for cytochrome reduction and the 
physiological reductant NADPH, the G141T mutant was found to exhibit a specific 
activity that is 30% less than that of the wild type reductase, indicating that the conserved 
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glycine residue helps modulate electron transfer.  A distinctive characteristic of CPR is 
that the thermodynamically stable neutral FMN SQ serves as the primary electron donor 
to cytochrome P450.  This phenomenon is the direct result of the substantial separation of 
the midpoint potentials for the OX/SQ and SQ/HQ redox couples (-43 mV and -280 mV, 
respectively). Reductive titrations of the G141T mutant revealed a significantly lower 
formation of the FMN SQ at thermodynamic equilibrium in both CPR and the FBD.  The 
direct measurement of the midpoint potentials for this mutant indicated values for the 
OX/SQ and SQ/HQ couples of -250 mV and -218 mV, respectively.  Thus, the midpoint 
potential for the OX/SQ couple has decreased substantially resulting in a significant loss 
in stability of the SQ state with the HQ state becoming the most stable 
thermodynamically.  When wild-type CPR is mixed with an equimolar concentration of 
NADPH in a stopped-flow spectrophotometer, the disemiquinoid species is formed.  
However, when the experiment is repeated with G141T CPR, the FAD OX, FMN HQ 
species are preferentially formed.  This data suggests that G141T CPR utilizes the FMN 
HQ as the primary electron donor to the cytochrome rather than the FMN SQ, but 
apparently in a less efficient manner.  Thus the conserved glycine residue plays a critical 
role in stabilizing the reduced forms of the FMN cofactor, and in determining the 
mechanism of electron transfer in CPR.  
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Introduction 
Physiological role of microsomal cytochrome P450 system: Found predominantly on the 
endoplasmic reticulum in liver cells, the microsomal cytochrome P450 system consists of 
two integral membrane proteins, cytochrome P450 reductase (CPR) and cytochrome 
P450.  The role of CPR in the reaction is to couple a two-electron donor (NADPH) with a 
one-electron acceptor (cytochrome P450) (figure 1). In addition to reducing cytochrome 
P450, CPR also reduces squalene monooxygenase, heme oxygenase, and cytochrome b5, 
however for the purpose of this thesis, the focus will be on the microsomal cytochrome 
P450 system.  The structure of CPR and its mechanism of catalysis will be discussed in 
more detail later in the thesis.  While animals contain only one CPR gene, the human 
genome project has identified 58 P450 pseudogenes in humans [1, 2].  CPR is capable of 
supporting catalysis of dozens of different P450s, as is evidenced by a molar ratio of 
P450 to CPR in microsomes of about 5-10 to 1 [3, 4].   
P450s perform a wide variety of reactions throughout nature.  Plants use P450s 
much more extensively than mammals; for example, Arabidopsis thaliana has 286 P450s 
compared to 58 for humans [1, 5].  In plants, many of the P450s are used for the 
biosynthesis of specific natural products that are used for coloration and defense.  While 
mammals also use P450s for the synthesis of some important steroids and eicosanoids, 
the majority of P450s in mammals are used for xenobiotic transformations [5]. 
Xenobiotics are chemical substances that are foreign to a biological system, including 
environmental agents, carcinogens, insecticides, naturally occurring compounds, and 
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Figure 1:  A cartoon showing the flow of electrons in the microsomal cytochrome 
P450 system.  On the left is cytochrome P450 reductase while the heme-iron of 
cytochrome P450 is on the right. 
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industry.  In fact, most countries now require that all new drug candidates include 
information about which human P450 enzymes are involved in its metabolism [6, 7].  
P450s 1A2, 2C9, 2C19, 2D6, and 3A4 account for the majority of metabolism of drugs in 
humans [8-10].  It is important for pharmaceutical companies to study the P450s for two 
reasons.  First, P450 catalysis of drugs lowers their bioavailability, thus reducing their 
effectiveness.  Second, if a drug is administer in a pro-drug form, P450 catalyzed 
oxidation is required for conversion to the active form.  Given the role of P450s in drug 
metabolism and other xenobiotic transformations, a full understanding of the microsomal 
cytochrome P450 system is needed, including a detailed study of both cytochrome P450s 
and their primary redox partner, cytochrome P450 reductase. 
Cytochrome P450 catalytic cycle: Cytochrome P450s are heme-containing 
monooxygenases that catalyze a mixed-function oxidation as described in equation 1.   
(1) NADPH + H+ +O2 + RH  NADP+ + H2O + ROH 
The general catalytic cycle of P450s is shown in figure 2 [5].  CPR is responsible for 
donating a single electron to the heme iron of the P450 in step 2 of the reaction cycle. 
The only case where CPR is not the donor of the first electron to a microsomal P450 
occurs with truncated forms of P450s that are targeted to the mitochondria, in which case 
the iron-sulfur protein adrenodoxin serves as the electron donor [11].  However, it should 
be noted that the vast majority of P450s, including those involved in the metabolism of 
drugs and carcinogens, are located in the endoplasmic reticulum and are thus reduced by 
CPR [5].  The addition of the first electron reduces the iron from the ferric state to the 
ferrous state, allowing it to bind to O2 in step 3.  In step 4 of the reaction, a second 
























Figure 2: Generalized P450 Catalytic Cycle Fe = iron atom in P450 heme, RH = 
substrate, ROH = product, NADPH-P450 reductase = cytochrome P450 reductase, ox and 
red indicate the reduced and (1-electron) oxidized states of the reductase involved in the 
electron transfers. Reproduced from reference 5. 
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This second electron may come from CPR or from cytochrome b5, but as shown in figure 
2, CPR reduces cytochrome b5 [12, 13].  In step 5 a proton is added and in step 6, 
molecular oxygen is cleaved and water is released.  The departure of a water molecule 
leaves the FeO3+ complex wherein it is generally accepted that iron is Fe4+ and that the 
porphyrin ring is one-electron deficient [5].  There is still some debate as to the exact 
mechanism of steps 7 and 8, but they ultimately result in the release of the oxidized 
product (ROH) and the regeneration of the heme iron in the ferric state. 
Cytochrome P450 reductase and its domains: Cytochrome P450 reductase is a 
membrane bound electron transfer flavoprotein in the endoplasmic reticulum that utilizes 
two riboflavin-like cofactors, flavin adenine dinucleotide (FAD) and flavin 
mononucleotide (FMN).  It is one of only four known mammalian enzymes that contain 
both FAD and FMN, with the others being nitric-oxide synthase, methionine synthase 
reductase, and protein NR1 [14].  CPR has three domains:  the membrane anchor, the 
FMN-binding domain, and the FAD-binding domain; the two flavin-binding domains are 
connected by a flexible linker region.  A relatively short sequence of hydrophobic 
residues at the N-terminus form the member anchor.  Cleavage of the first 56 residues 
generates the soluble form of the enzyme, which is capable of passing electrons to the 
artificial electron receptor cytochrome c, but is incapable of reducing cytochrome P450s 
[15].  Since the soluble form of CPR was used throughout this study, it shall henceforth 
be referred to simply as CPR.  The crystal structure of rat CPR, lacking the membrane 



























Figure 3:  The architecture of cytochrome P450 reductase.  (A) Crystal structure of 
the soluble portion of rat cytochrome P450 reductase (PDB = 1AMO) [15].  The flavin 
cofactors are labeled.  (B) Gene map of the soluble portion of cytochrome P450 
reductase.  At the N-terminus is the FMN domain.  The flexible linker region, in 
brown, connects the FMN domain to the FAD domain, which also contains the 
NADPH binding sub-domain. 
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Closer investigation of the crystal structure of CPR reveals many important 
interactions.  Both flavin-binding domains display an α/β type structure.  The core of the 
FBD is composed of a five-stranded parallel β-sheet flanked by five α-helices.  This is 
structurally homologous to bacterial flavodoxins (figure 4).  A flexible linker connects 
the FBD to the FAD-binding domain, which also contains the NADPH binding sub-
domain.  Similar to ferredoxin-NADP+ reductase (FNR), the FAD-binding domain has a 
flattened, anti-parallel β-barrel while the NADPH binding sub-domain consists of a five-
stranded β-sheet sandwiched by α-helices (figure 5) [15].  The structural homology 
between the FBD and flavodoxins and the FAD-binding domain and FNR led to the 
conclusion that CPR evolved as a fusion of these two simple flavoproteins [15-19]. 
P450BM-3 enzyme (BM3) from Bacillus megaterium is homologous to the 
microsomal cytochrome P450 system.  This soluble (not membrane anchored) 
flavocytochrome contains a fatty acid hydroxylase P450 fused to a mammalian-like 
diflavin NADPH-P450 reductase as a single polypeptide [20-21].  Thus, BM3 is the 
entire microsomal cytochrome P450 system in a single peptide.  Due to its efficient 
electron transfer from NADPH to the P450 heme, BM3 has the highest catalytic activity 
yet determined for a P450 monooxygenase (17,000 min-1 with arachidonate) [22, 23].  
Although there is currently no crystal structure for the full BM3 protein, there is a 
structure for the heme and FMN domains, and there is a clear homology between the 

















C. beijerinckii flavodoxin 
FMN domain of CPR 
FMN Domain of BM3 
Figure 4:  A structural comparison of the C. beijerinckii flavodoxin (PDB = 4NUL ), the 
FMN binding domain of BM3 (PDB = 1BVY) (flavin cofactor not shown), and the FMN 
binding domain of CPR (PDB = 1AMO).  The FMN binding domains of CPR and BM3 are 
thought to have evolved from the bacterial flavodoxin.  All three structures share a clear 




















Ferredoxin Reductase FAD domain of CPR 
Figure 5:  A structural comparison of the Cyanobacterium anabaena ferredoxin 
reductase (PDB =  1QUE) and the FAD binding domain of CPR with the NADPH 
binding sub-domain (PDB = 1AMO).  The FAD cofactor is in the upper right portion 
of the structure in the sub-domain that has a flattened, anti-parallel β-barrel.  The 
NADPH binding sub-domain is at the bottom left of each structure and consists of a 5-
stranded β-sheet sandwiched by α-helices.  The FAD binding domain of CPR is 
thought to have evolved from ferredoxin reductase. 
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 In CPR, the two flavin cofactors do not overlie each other, but rather are end on 
end with an angle of 150° between the planes of the rings; the closest distance between 
the rings is 3.5 Å and occurs between the C7M atoms (figure 6).  The close arrangement 
of the flavin cofactors suggests that electron transfer occurs directly between the flavin 
cofactors and is not mediated by any residue atoms [15].  The initial crystal structure of 
rat CPR was determined in the presence of NADP+, but the electron density of the 
nicotinamide cofactor was 30% of the rest of the molecule, indicating that the cofactor 
adopts multiple conformations.  Two NADP+ conformers have been proposed which fit 
the electron density map.  In one case the C4 atom of nicotinamide (the hydride donor) is 
9 Å away from the N5 of the FAD cofactor (the hydride acceptor) while in the other it is 
14 Å away [15].  These distances were too long for direct hydride transfer.  A closer look 
at the crystal structure revealed that the FAD isoalloxazine ring is shielded by an 
aromatic amino acid residue (W677), leading to the proposal that for hydride transfer to 
occur, conformational changes must accompany the binding of the reduced nicotinamide 
[15, 19, 25-27].  Mutagenesis of W677 in rat CPR revealed a crystal structure where the 
nicotinamide of NADP+ bound close to the isoalloxazine ring, engaging in π-π stacking 
interactions, with a distance between the C4 of the nicotinamide ring and the N5 of the 



















Figure 6:  Stereoview of the cofactor arrangement in rat CPR and multiple conformers for 
the bound NADP+. Electrons flow from NADPH to FAD and then to FMN. The FMN and 
FAD are represented by ball-and-stick, with the xylene portions of the isoalloxazine rings 
oriented toward each other. The adenine portion of NADP+ binds in a single conformation 
(ball-and-stick) while the nicotinamide (stick only) binds in multiple conformations. By 
rotation about the PN—O—PA bond, the nicotinamide ring could displace W677 at the re-
side of the FAD ring, placing it in the optimum orientation for hydride transfer from the 
NADPH to the N5 position of the FAD cofactor.  Reproduced from reference 15. 
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Human [29] and rat [30, Swenson unpublished data] FAD-binding domain and 
FBD have been separately expressed and purified.  The isolated domains are able to fold 
properly and can bind the appropriate flavin cofactors.  The FBD is able to bind the FAD-
binding domain and cytochrome c [29].  A reconstituted system consisting of the isolated 
domains is able reduce cytochrome c, but with only 2% efficiency compared to CPR [29].  
Further studies on the isolated domains of human CPR by Munro et al. demonstrated that 
there is little difference between the midpoint potentials of the flavin cofactors in the 
isolated domains and in CPR (Table 1) [31]. 
 Although the above data suggests that the flavin binding domains exist in discrete 
environments, a growing body of evidence argues that the domains interact during the 
catalytic cycle.  Hubbard et al demonstrated that binding of NADP+ in the W677 mutant 
of rat CPR caused the FBD to shift, increasing the distance between the two flavin 
cofactors by up to 3 Å [28].  The effect of NADPH binding was further studied by 
Grunua et al.  Through a series of isothermal titration calorimetry studies and pre-steady-
state kinetic measurements Grunua et al demonstrated that binding of NADPH caused a 
conformational change between the flavin domains, making intramolecular (FAD to 
FMN) and intermolecular (FMN to cytochrome c) electron transfer more favorable [32].  
Mechanism of CPR electron transfer: In any given reaction CPR has two 
substrates, an electron donor (NADPH) and an electron acceptor (cytochrome c).  Under 
physiological conditions, the cytochrome is in the P450 superfamily, but since many in 
vitro studies have been conducted with cytochrome c as the electron acceptor, the 
mechanism of electron transfer will be outlined with cytochrome c as the electron 
acceptor.  This mechanism should still be physiologically relevant because cytochrome c 
 20 
and cytochrome P450 have overlapping binding sites on CPR [33-35].  There are two 
basic kinetic mechanisms for two-substrate enzymes, the Ping-Pong and Bi-Bi 
mechanism, with the Bi-Bi mechanism further subdivided into ordered and random 
(figure 7).  Studies on a number of diflavins suggest a random Bi-Bi kinetic mechanism 
for diflavins in general [36].  However, recent investigations show that cytochrome c will 
not bind to CPR unless the flavoprotein has been reduced by NADPH; leading to the 
conclusion that CPR may actually utilize an ordered Bi-Bi kinetic mechanism [32]. 
Flavin cofactors have the unique ability to undergo three different redox states:  
oxidized, semiquinone (one-electron reduced), and hydroquinone (two-electron reduced) 
which allows flavoproteins to serve as electron bridges between obligate two-electron 
donors such as NADPH and obligate one-electron acceptors such as cytochrome P450s 
(figure 8).  In addition to the multiple redox states, the semiquinone form of the flavin 
cofactor can exist in the cationic, neutral, or anionic forms, but only the neutral and 
anionic forms are found in flavoproteins [36, 37].  The anionic and neutral semiquinone 
can easily be distinguished by their spectral properties, and thus are called “red” and 
“blue” respectively [38, 39].  Rat CPR exclusively utilizes the neutral blue semiquinone.  
Interestingly, the blue semiquinone is air-stable in CPR and other diflavins, which is in 
stark contrast to the other reduced states of the flavin cofactors that readily react with 
oxygen to form superoxide [36, 40].   
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C. Ordered Bi-Bi 
Figure 7:  Different proposed mechanisms for CPR and other enzymes with two 
substrates and two products. (A) The ping-pong mechanism has the first product 
dissociate from the enzyme before the second substrate binds.  (B) In the random 
bi-bi mechanism, both substrates bind before product formation.  Which substrate 
binds first or which product is released first is random.  (C) Like the random bi-bi 
mechanism, the ordered bi-bi mechanism has both substrates bind before any 
product is formed.  However, in this case, the order of substrate binding and 



































Figure 8:  The three redox states of the flavin cofactor.  The one electron reduced 
(semiquinone) state can be either the neutral blue semiquinone or the anionic red 
semiquinone.  CPR exclusively utilizes the neutral blue semiquinone, which means that 
the N5 position is protonated. 
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 The two flavin cofactors of CPR give rise to nine possible redox state 
combinations, but since NADPH is an obligate two-electron donor, the number of 
physiologically relevant states is reduced to five (figure 9). For obvious reasons the fully 
oxidized reductase is incapable of reducing cytochrome c, leaving only the two and four 
electron reduced forms as possible electron donors.  The four-electron-reduced reductase 
can be eliminated as the electron donor to cytochrome c because it takes up to 8 hours of 
incubation under anaerobic conditions in the presence of NADPH and the NADPH 
regenerating system to form, which clearly is not physiologically relevant [41].  The FAD 
HQ - FMN OX can also be eliminated as cytochrome c receives electrons from the FMN 
cofactor.  This leaves only two forms of the reductase, the disemiquinoid and the FMN 
hydroquinone, that can serve as the electron donor.  The midpoint potentials of the two 
states provide the answer.  For the FMN cofactor of human CPR, the OX/SQ couple is -
66 mV while the SQ/HQ couple is -269 mV; thus it is significantly easier to form the 
disemiquinoid species than the FAD OX - FMN HQ species [31].  Also, reduction of 
CPR by a stoichiometric amount of NADPH led to the formation of the disemiquinoid 
species, not the FAD OX - FMN HQ species [42].  Finally, stopped-flow kinetic studies 
on human CPR showed that the rate of formation of the FMN HQ is significantly slower 
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 Figure 9:  The 9 possible combinations of flavin cofactor redox states in CPR.  Since NADPH 
is an obligate two electron donor, only the two and four electron reduced forms of CPR (in red) 
are theoretically capable of donating electrons to cytochrome c.  Additional evidence, which is 
expanded upon in the text, suggests that for wild type CPR the disemiquinoid form is the 
primary electron donor to cytochrome c. 
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 Muratatliev et al combined this data to suggest a general kinetic mechanism of 
electron transfer (Figure 10) [36].  In the first step of the reaction, NADPH binds to CPR 
in a bimolecular step with a kon of 1-3 x 107 M-1 s-1 for rat CPR [43, 44].  Hydride transfer 
occurs in step two while acceptor (cytochrome c) binding is shown in step three.  Based 
on a comparison of the hydride transfer rate to FAD and steady-state catalysis rate, 
hydride transfer from NADPH is the rate-limiting step [43-45].  In step three, interflavin 
electron transfer occurs.  Based on stopped-flow-kinetic studies, this electron transfer 
event occurs at least as fast as hydride transfer to FAD.  In step four, the acceptor is 
reduced by the FMN SQ.  The reduction of both molecules of cytochrome c can be 
described in terms of first order Michaelis-Menten kinetics rather than second order 
kinetics, leading to the conclusion that binding of cytochrome c is not rate limiting [36].  








































































Figure 10:  Catalytic cycle of diflavin reductases, including CPR, originally proposed by 
Murataliev et al. Ao is the oxidized substrate and Ar is the reduced substrate (cytochrome 
c).   Based off of reference 36. 
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Project history: Given the wide variety of electron transfer mechanisms and redox 
potentials found in flavoproteins, it is evident that the protein environment plays a 
substantial role in modulating the redox properties of the flavin cofactor.  The goal of this 
project is to gain a better understanding of how the FMN binding loop in CPR modulates 
the redox properties of the FMN cofactor.  Since CPR is homologous to the reductase 
domains of BM3, and the FBD of CPR is homologous to bacterial flavodoxins, the FMN 
binding loops from all these species were compared (Figure 11).   Somewhat 
surprisingly, the FMN binding loops of these homologous domains showed extensive 
variability in the size, sequence, and conformation.  Despite these differences, all of the 
loops contained a conserved glycine residue.  A comparison of the crystal structures of 
these loops shows that the backbone carbonyl of the conserved glycine residue is 
positioned to form a hydrogen bond with the N5 position of the isoalloxazine ring (Figure 
12).  The N5 position is protonated in both the semiquinone and hydroquinone forms 
(Figure 8), leading to the hypothesis that the hydrogen bond helps to stabilize the reduced 





(BM3)   -Ala534-Ser-Tyr-Asn-Gly-His-Pro-Pro541- 
 
(CPR)   -Ala138-Thr-Tyr     Gly-Asp-Pro-Thr146- 
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(CbFld) -Ser 54-Ala-Met             Val-Leu61 
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(DvFld) -Ser 58-Thr-Trp         Glu-Leu-Gln68-   
                                                                   









Comparison of FMN binding loops in flavoproteins 
Figure 11:  Sequence comparison of the FMN binding loops in BM3, CPR, C. beijerinckii 
flavodoxin, and D. vulgaris flavodoxin.  The conserved glycine residue is highlighted in 
pink.  The part of the loop that interacts with the N5 position of the isoalloxazine ring is 























Comparison of re-face loop structures (near N5) 
Orange:  DvFldn 
Green:  CPR 
Blue:  BM3 
Pink:  Conserved Gly 
Figure 12:  Structural comparison of the FMN binding loops in D. vulgaris flavodoxin, 
CPR, and BM3.  The conserved glycine residue is highlighted in pink.  The N5 position of 
the isoalloxazine ring is marked with a blue dot. 
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 The role of the conserved glycine residue has already been rigorously explored in 
both Desulfovibrio vulgaris [46] and Clostridium beijerinckii [47].  The FMN binding 
loop in D. vulgaris flavodoxin is approximately four residues longer than the equivalent 
loop in CPR, which leads to different interactions with isoalloxazine ring.  However, 
crystal structures of the oxidized flavodoxin and its mutants show the backbone carbonyl 
of the conserved glycine, residue 61, positioned to make a hydrogen bond with the N5H 
of the reduced flavin cofactors.  Mutational analysis of glycine 61 to alanine, valine, 
leucine, and asparagine showed that all mutations destabilized the semiquinone state and 
that the extent of destabilization increases with the bulkiness of the side chains, with the 
β-branched side chain of valine causing the largest change in midpoint potentials [46].  
Interestingly, all mutations of glycine 61 increase the OX/SQ midpoint potential and 
lower the SQ/HQ midpoint potential.  This data supports the hypothesis that the hydrogen 
bond between glycine 61 and the N5H of the semiquinone is important for the regulation 
of the redox properties of the FMN cofactor [46].  Crystal structures of the mutant 
flavodoxins show that the steric constraints of the loop are such that insertion of a side 
chain at position 61, even the methyl group of alanine, will cause a 5 Å shift in the loop, 
altering the contacts with the flavin cofactor, signifying that a degree of caution is 
necessary for interpreting the results of this mutational analysis. 
 The FMN binding loop in C. beijerinckii was studied through mutational analysis 
of the conserved glycine 57 residue by Ludwig and Swenson [47].  The C. beijerinckii 
FMN binding loop is only two residues larger than the FMN binding loop in CPR, rather 
than four residues, as is the case with D. vulgaris flavodoxin.  Thus, studies on C. 
beijerinckii should be more relevant for CPR.  Ludwig and Swenson rigorously explored 
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the role of glycine 57 by mutating it to alanine, aspartate, asparagine, and threonine.  As 
with the D. vulgaris flavodoxin, the addition of a side chain caused the OX/SQ midpoint 
potential to decrease and the SQ/HQ midpoint potential to increase, with the larger side 
chains causing the largest change in midpoint potentials [47].  The introduction of the β-
branched side chain of threonine at position 57 caused the OX/SQ midpoint potential to 
decrease by 178 mV.  This decrease is over 100 mV larger than that caused by mutation 
to alanine, aspartate, or asparagine.  The large change in midpoint potentials for the G57T 
mutant caused all three oxidation states to be present in significant amounts throughout 
most of the reductive titration, which contrasts with the results for the wild type 
flavodoxin [47].   
Wild type C. beijerinckii flavodoxin has three different redox states, cis O-down, 
trans O-down, and trans O-up, with the fully oxidized flavin existing predominantly in 
the cis O-down conformation (figure 13).  In this conformation, the backbone carbonyl is 
pointed away from the isoalloxazine ring.  Upon reduction of the flavin cofactor to either 
the semiquinone or hydroquinone state, glycine 57 assumes the trans O-up conformation 
with the backbone carbonyl pointed directly at the N5H [47].  This conformational 
change is linked to the redox state of the FMN cofactor and strongly suggests that residue 












Figure 13: Conformations of the peptide backbone at residues 56-59 in C. 
beijerinckii flavodoxin. The position of O57 and the configuration of the peptide are 
the features that distinguish the three observed conformers. In the O-up form, the 
carbonyl oxygen of residue 57 is hydrogen-bonded to the flavin N5H. Side chains 
have been omitted to simplify the drawings. Nitrogen atoms are filled; C and O 
atoms are open, with larger radii assigned to the oxygens. Residues are numbered at 
the C  atoms. The heteroatoms of the isoalloxazine ring are labeled, and the ribityl 
side chain has been omitted beyond C1'.  Reproduced from reference 47. 
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 Plotting the phi and psi angles of these conformations on a Ramachandran plot 
provides some insights into the potential cause of the large shift in midpoint potentials for 
the glycine to threonine mutant.  The cis O-down conformation (oxidized FMN) has phi-
psi angles of -79, 128 while the trans O-up conformation (reduced FMN) has phi-psi 
angles of approximately 50, -130; placing the trans O-up conformation in a portion of 
Ramachandran space that is normally only available to glycine [48, 49] (Figure 14).  The 
G57T mutant in C. beijerinckii is capable of achieving these phi-psi angles, but the large, 
β-branched side chain of threonine should significantly raise the energy necessary for 
residue 57 to rotate to the trans O-up conformation necessary to interact with the N5H of 
the isoalloxazine ring [47].  Based on the redox potentials, the G57T mutant should have 
at most 65% SQ during the reductive titration.  A crystal structure of the mutant 
flavodoxin at maximal SQ formation shows electron densities consistent with 60% of 
residue 57 in the trans O-up conformation and 40% in the trans O-down conformation, 
further strengthening the claim that the conserved glycine residue plays a crucial role in 
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Figure 14:  Ramachandran plot of the conserved glycine residue (G57) in the FMN 
binding loop of wild type and G57T mutant C. beijerinckii flavodoxin at various redox 
states.  The position of the conserved glycine residue (G141) in the FMN binding loop 
of CPR is marked with a star. 
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Project Objectives: The objective of this project is to extend the studies of the 
conserved glycine residue in bacterial flavodoxins to the multidomain, mammalian 
homolog, CPR.  We sought to determine if the conserved glycine residue interacts with 
the N5H of the isoalloxazine ring in the same manner as the flavodoxins.  The crystal 
structure of rat CPR shows the backbone carbonyl of the conserved glycine, residue 141, 
is already pointed directly at the N5H of oxidized flavodoxin (figure 15).  It should be 
noted that the main chain carbonyl is slightly out of hydrogen bonding range with an 
inter-atomic distance of 3.66 Å.   Previous studies on the role of the conserved glycine 
residue had focused predominantly on structural effects of the mutation and the midpoint 
potentials.  However, we also wanted to probe the effect of mutation of glycine 141 on 
the electron transfer mechanism in CPR.  Previous studies on C. beijerinckii and D. 
vulgaris clearly demonstrated that a large, β-branched side chain such as valine or 
threonine had the largest effect on the midpoint potentials of the FMN cofactor.  Building 
off of these results, we choose to mutate glycine 141 to threonine in both CPR and the 
FBD so that we could significantly perturb the interaction between the main chain 










   FMN 
Figure 15:  The FMN binding loop of CPR.  The backbone carbonyl of glycine 
141 is pointed directly at the N5 position in the oxidized isoalloxazine ring. 
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Materials and Methods 
Materials: Mutagenic primers were ordered from Sigma-Genosys. Competent 
Escherichia coli cells (strain DH5α Max Efficiency) were purchased from Invitrogen 
while the BL21(DE3) Rosetta strain was purchased from Novagen.  Horse heart 
cytochrome c, FMN, NADPH, and NADP+ were all purchased from Sigma. 
Isopropylthiogalactoside (IPTG) was obtained from Research Products International. 
Potassium ferricyanide was obtained from Fisher.  Sodium dithionite was obtained from 
JT Baker. Indigo disulfonate, anthraquinone-2,6-disulfonate, and anthraquinone-2-
sulfonate were all obtained from Fluka.  All other chemicals were analytical grade. The 
Quikchange site-directed mutagenesis kit was from Stratagene.  The Qiaprep Spin 
miniprep kit was from Qiagen. 
Site-Directed Mutagenesis: Soluble rat CPR (lacking the N-terminal membrane anchor) 
and the isolated FMN-binding domain (FBD) were expressed in E. coli strain BL21(DE3) 
Rosetta from the appropriate pT7-7 plasmid constructs [unpublished results].  The G141T 
mutation was generated in both CPR and the isolated FMN domain using a Quikchange 
kit.  Mutagenic oligonucleotides for generating the G141T mutation were 5’-
GCCACATACACAGAGGGCGACC -3’ and 5’-GGTCGCCCTCTGTGTATGTGGC-
3’.  The G141T DNA was transformed into competent E. coli strain DH5α Max 
Efficiency cells as described in the vendor protocol.  Plasmid DNA was purified by a 
Qiaprep Spin miniprep kit as described by the vendor protocol.  Mutations and the 
sequence integrity of the entire open-reading frame were verified by automated DNA 
sequencing analyses performed by the Plant Microbe Genomics Facility at the Ohio State 
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University.  Plasmids containing the appropriate mutation were then transformed into 
competent E. coli strain BL21(DE3) Rosetta for over-expression of the holoproteins. 
CPR Overexpression and Purification: E. coli strain BL21(DE3) Rosetta cells were 
cultured at 37° C in LB medium containing ampicillin (100 ug/mL) and chloramphenicol 
(35 ug/mL) until the OD at 600 nm reached approximately 0.8 – 1.0, at which point IPTG 
was added to a final concentration of 0.4 mM and the temperature was lowered to 25° C 
for overnight incubation [50].  Cells were harvested by centrifugation, and the cell pellets 
were suspended in 50 mM Tris, pH 7.7 containing 0.1 mM EDTA, 0.05 mM 
dithiothreitol and 10% glycerol (Buffer A).  Cells were lysed by passage through the 
French press cell at 12000 psi.  The cell lysates from the expression of the WT CPR and 
the G141T CPR mutant were purified by affinity chromatrography using a resin with 
immobilized 2’, 5’-ADP following the procedure of Rock et al followed by ion exchange 
chromatography.  After loading the lysate onto the affinity resin, the column was washed 
with Buffer A and Buffer A containing 5 mM adenosine; the bound CPR protein was 
eluted with Buffer A containing 20 mM 2’(3’) AMP and 100 mM NaCl [51].  Fractions 
that were reasonably pure, as determined by SDS PAGE analysis, were concentrated by 
ultrafiltration using an Amicon stirred cell apparatus with a 10 KDa NMWL filter.  The 
concentrated CPR solution was loaded onto a DEAE Sephacel ion exchange column and 
washed with Buffer A.  CPR was eluted with a linear salt gradient from 0 mM – 400 mM 
NaCl in Buffer A.  The purity of selected fractions was confirmed by SDS PAGE and 
fractions over 95% pure were pooled and concentrated by ultrafiltration using an Amicon 
ultracentrifugal filtration device (Centricon-10).  The concentrated solution was diluted 
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with Buffer A and re-concentrated several times so as to remove the NaCl and 2’(3’) 
AMP.  The concentrated protein was then stored at -80° C. 
FBD Over-expression and Purification: The wild type and G141T FBD were over-
expressed in the manner described above, however it was purified by DEAE Sephacel ion 
exchange and gel permeation chromatography.  Cell lysate was loaded onto the ion 
exchange column and washed with Buffer A and then Buffer A containing 200 mM 
NaCl.  The FBD was eluted with a linear salt gradient from 200 mM to 500 mM NaCl in 
Buffer A. Fractions that were reasonably pure, as determined by SDS PAGE analysis, 
were concentrated by ultrafiltration with an Amicon stirred cell apparatus (10 KDa 
NMWL filter).  The concentrated CPR solution was subjected to gel permeation 
chromatography using a Sephacryl S-200-HR resin. The purity of selected fractions was 
confirmed by SDS PAGE and fractions over 95% pure were pooled and concentrated by 
ultrafiltration with an Amicon Centricon device (10 KDa NMWL) [52].  Protein 
concentrations were determined using the following molar extinction coefficients (M-1 
cm-1) at 455 nm: CPR 20,357; FBD 10,800 [unpublished data]. 
Spectral Analyses and Redox Titrations: All ultraviolet—visible absorbance spectra 
were recorded on an Agilent 8453 photodiode array spectrophotometer at 25° C.  
Anaerobic titrations of CPR and FBD by sodium dithionite and NADPH were performed 
in 270 mM potassium phosphate buffer, pH 7.7.  NADPH, sodium dithionite, and 
potassium ferricyanide solutions were made anaerobic by extensive bubbling with argon.  
Protein samples (1 mL, final concentration 5 uM – 20 uM) were placed in a special 
sealable titration cuvette and made anaerobic by repeated cycles of partial vacuum 
evacuation and flushing with argon.   Once complete reduction of the flavin cofactors 
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was achieved through the addition of sodium dithionite, the solution was titrated with 
potassium ferricyanide to fully re-oxidize the system.  After the addition of each aliquot 
of reductant/oxidant the system was allowed to sit until no more spectral changes were 
observed, indicating that the system had reached thermodynamic equilibrium.  
Steady-State Turnover Kinetic Analyses: Cytochrome c reductase activity was 
measured under saturating substrate concentrations with NADPH as the reductant.  Assay 
solutions contained 270 mM potassium phosphate buffer, pH 7.7, 100 uM NADPH, 65 
uM cytochrome c and CPR concentrations ranging from 1.15 to 15 nM  [53, 54].  
Reduction of cytochrome c was monitored at 550 nm with Δε = 21 mM-1 cm-1 [55].  The 
ferricyanide reductase activity assay was also performed in 270 mM potassium phosphate 
buffer, pH 7.7.  Reagent concentrations were as follows:  100 uM NADPH, 500 uM 
potassium ferricyanide, and CPR concentrations ranging from 1.15 to 21 nM.  Reduction 
of ferricyanide was monitored at 420 nm with Δε = 1.04 mM-1 cm-1 [56]. 
Determination of Oxidation—Reduction Potentials: The midpoint potential of the OX/SQ 
couple of the FMN-binding domain was established spectrophotometrically by 
equilibration with a standard indicator dye during anaerobic titration with sodium 
dithionite [31, 47].  Protein samples (1 mL, final concentration 15 uM – 20 uM) were 
placed in a special sealable titration cuvette along with an indicator dye (final 
concentration 20 uM) and made anaerobic by repeated cycles of partial vacuum 
evacuation and flushing with argon.  The indicator dye used in the determination of the 
OX/SQ midpoint potential was anthraquinone-2,6-disulfonate (Em = -184 mV) or 
anthraquinone-2-sulfonate (Em = -225 mV). All measurements were performed in 270 
mM potassium phosphate, pH 7.7 at 25° C.  The spectrum at each point in the reductive 
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titration was compared to standard spectra for the redox dyes and each of the three redox 
states of the flavin cofactors.  Multi-component spectral analyses were used to determine 
the relative concentrations of each of the various redox species of the FMN cofactor and 
the oxidized and reduced forms of the indicator dyes.  The relative concentrations of each 
redox species at each point of the titration were then inserted into the Nernst equation 
(Equation 2) to calculate a midpoint potential.  Titration points that had significant 
concentrations of all five redox species were averaged together to determine the midpoint 
potential of the OX/SQ couple.  
(2) E°SQ/OX = E°dye – ((R*T)/(n*F)) * ln( ([dyeRED]*[OX]) / ([dyeOX]*[SQ]) ) 
The midpoint potential for the SQ/HQ couple was calculated in the same manner and 
then verified using equations 3 and 4.  
(3) ΔE = E 1 - E 2 
(4) ([I]/S)max = (K1/2/(2+K))  
Where ([I]/S)max is the maximum concentration of semiquinone formed and S is the total 
protein concentration [57]. 
Pre-Steady-State Kinetic Analyses: All pre-steady-state kinetic measurements were 
performed using a Hi-Tech Scientific Model SF-61 stopped flow spectrophotometer.  
Reactions were initiated by the rapid mixing of equal volumes of each solution in the 
combination mixing/flow/observation cell (1-cm pathlength) of the instrument.  
Absorbance changes were digitally recorded and reaction time courses fit to standard 
single (5a), double (5b), or triple (5c) exponential equations using the Marquardt 
Levenberg iterative algorithm.  
(5a) Aλ = A1*e-(k1*t) + C 
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(5b) Aλ = A1*e-(k1*t) + A2*e-(k2*t) + C 
(5c) Aλ = A1*e-(k1*t) + A2*e-(k2*t) + A3*e-(k3*t) + C 
 Unless otherwise stated, measurements were carried out at 25° C under anaerobic 
conditions.  All experiments with FBD, with the exception of single turnover assays, 
which were performed in 100 mM potassium phosphate, pH 7.0, were performed in 270 
mM potassium phosphate, pH 7.7.  All experiments with CPR, including single turnover 
assays, were performed in 100 mM potassium phosphate, pH 7.0.  All buffers were made 
oxygen-free by extensive sparging with argon before use.  Reduction of the oxidized 
flavin cofactors was monitored at 455 nm (Δε OX-HQ per flavin = 9.16 mM-1 cm-1), 
formation and loss of the semiquinone state was monitored at 581 nm (Δε per flavin = 
4.21 mM-1 cm-1)). For experiments involving pre-reduced flavin cofactors, the reducing 
agent (sodium dithionite or NADPH) was titrated into a sealed cuvette containing the 
flavoprotein until the desired redox state was achieved as determined by the absorbance 
spectrum of the solution.  The reduced flavoprotein was then transferred anaerobically to 
the stopped-flow instrument via a gas-tight syringe.   
Single Turnover Assay: Single turnover assays were performed using a Hi-Tech 
Scientific Model SF-61 stopped flow spectrophotometer and all solutions were made 
anaerobic and/or pre-reduced as described above.  One mixing chamber contained 10 uM 
CPR and the other mixing chamber contained 10 uM NADPH and varying concentrations 
of cytochrome c (10.5 uM – 311.5 uM).  The turnover rate was calculated by monitoring 
the reduction of cytochrome c at 550 nm (Δε = 21 mM-1 cm-1) [55].  Absorbance changes 
were digitally recorded and reaction time courses fit to a standard single exponential 
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equation (5a) using the Marquardt Levenberg iterative algorithm.  Kmax and Kd were 
calculated using equation 6. 
(6) Ki = (Kmax*[S]) / (Kd + [S]) 
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Results 
FBD Redox Titrations: To determine the effect of the G141T mutation on the FMN 
cofactor alone, a redox titration was performed on the G141T FBD.  Similar to wild type 
FBD, the oxidized G141T FBD had a characteristic absorbance peak at 455 nm with a 
slight shoulder at 470 nm. Addition of sodium dithionite reduces the FMN cofactor from 
the oxidized state to the semiquinone state and then to the hydroquinone state.  Reduction 
of the flavin cofactor decreases the absorbance at 455 nm while formation of the 
semiquinone causes a band centered at 581 nm to form.  As more dithionite is added, the 
FMN cofactor becomes fully reduced, causing the band at 581 nm to decrease back to the 
baseline level while the band at 455 nm decreases further.  The spectral characteristics of 
G141T FBD upon reduction with sodium dithionite were quite different than wild type 
FBD (figures 16).  At first glance, G141T FBD exhibits almost no formation of a band 
centered at 581 nm, suggesting that the majority of the flavin cofactors exist in either the 
fully oxidized or fully reduced state, even when one electron equivalent has been added 
to the solution.  A more detailed analysis reveals that G141T FBD has a peak absorbance 
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Figure 16:  Spectral properties of the FBD during redox titration.  (A) 20 uM 
G141T FBD and (B) 20 uM wild type FBD were reduced in a stepwise manner by 
addition of substoichiometric volumes of sodium dithionite (2 mM).  After each 
addition of sodium dithionite, the system was allowed to fully equilibrate before 
the final spectrum was recorded.  Experiments performed at 25° C in 270 mM 
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Figure 17:  A comparison of the maximal semiquinone formation of wild type and 
G141T FBD during a redox titration with sodium dithionite.  Absorbance at 581 nm is 
a measure of the amount of flavin cofactor in the semiquinone state.  Titrations were 
performed at 25° C in 270 mM potassium phosphate, pH 7.7. 
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FBD Midpoint Potential: Given the significant change in the extent of semiquinone 
formation for the G141T FBD, the one-electron reduction potential of each flavin couple 
was determined at 25° C and pH 7.7 by equilibration with redox dyes having an 
established Em value [47].  The OX/SQ midpoint potential was determined to be -253 mV 
using anthraquinone-2,6-disulfonate (Em = -184 mV) as the indicator dye.  Since there 
was a large difference between the OX/SQ midpoint potential and the Em of the dye, 
there was little overlap between the five possible redox states in the system, which makes 
the calculations more difficult and error prone (figure 18a).  To correct for this, the 
OX/SQ midpoint potential measurement was repeated using anthraquinone-2-sulfonate 
(Em = -225 mV).  This experiment yielded a midpoint potential of -250 mV.  The greater 
overlap of all five redox states (figure 18b) and the reproducibility of the results increased 
our confidence in the accuracy of our calculation.  Using the data from the 
anthraquinone-2-sulfonate titration, the SQ/HQ midpoint potential for the FMN cofactor 
of G141T FBD was calculated to be -219 mV.  To verify the accuracy of the midpoint 
potential, it was recalculated using equations 3 and 4, yielding a value of -218 mV.  
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Figure 18:  Multi-component analysis of redox titration of G141T FBD with sodium 
dithionite. (A) Indicator dye is anthraquinone-2,6-disulfonate (Em = -184 mV).  Most of 
the indicator dye is reduced before maximum semiquinone formation occurs.  (B)  
Indicator dye is anthraquinone-2-sulfonate (Em = -225 mV).  In this titration, half of the 
indicator dye is reduced when maximum semiquinone formation occurs.  Both titrations 
were performed in 270 mM potassium phosphate, pH 7.7.  Indicator dye was at a 
concentration of 20 uM, FBD concentrations ranged from 15-20 uM, and titration was 
performed with 3 mM sodium dithionite. 
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 For the FBD of human CPR, the OX/SQ and SQ/HQ midpoint potentials are -43 
mV and -280 mV respectively (table 1) [31].  Although experiments in this lab were 
conducted on rat CPR, the high level of homology between rat and human CPR, 
particularly in the FMN binding loop, make comparisons of the midpoint potentials valid 
(figure 19) [58].  Compared to wild type FBD, the OX/SQ midpoint potential of the FMN 
cofactor of G141T FBD was decreased by over 200 mV, making it more negative than 
unbound FMN (-238 mV) [59].  Conversely, the SQ/HQ midpoint potential was 
increased by 60 mV, so that it is now less negative than the OX/SQ couple (figure 20).  
The inversion of the relative midpoint potentials makes it thermodynamically more 
favorable for the FMN cofactor to be in the hydroquinone form rather than the 
semiquinone form.  Since the reductive titration was allowed to reach thermodynamic 
equilibrium, this offers a viable explanation for the diminished semiquinone formation 
observed during the dithionite titration of the G141T FBD.  Munro et al demonstrated 
that for human CPR, the midpoint potential of the flavin cofactors in the isolated domains 
is similar to the midpoint potential in CPR [31].  Given the high homology between 
human and rat CPR, we assume that the midpoint potentials established in rat G141T 
FBD are similar to the midpoint potentials of the FMN cofactor in G141T CPR. 
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Flavin Cofactor Reduction Potential (mV) 
 FMN cofactor  FAD cofactor 
Protein OX/SQ SQ/HQ OX/HQ   OX/SQ SQ/HQ OX/HQ 
rG141T FBD -250 +/- 6 -219 +/- 5 -235 +/- 6     
hWT FBD -43 +/- 7 -280 +/- 8 -235 +/- 8     
hWT FAD     -286 +/- 6 -371 +/- 7 -329 +/- 7 







Table 1:  Comparison of the midpoint potentials of the flavin cofactors for human 
wild type and rat G141T CPR and their domains.  G141T FBD measurements were 
made using multi-component analysis of the redox titration with sodium dithionite.  
The titration was carried out at 25° C in 270 mM potassium phosphate, pH 7.7 with 20 
uM anthraquinone-2-sulfonate as the indicator dye.  All wild type data comes from 
reference 31.  Wild type experiments were carried out on human CPR, not rat CPR, in 
100 mM potassium phosphate, pH 7.0.  Midpoint potentials were measured with a 
Calomel electrode during a redox titration of the protein with sodium dithionite. 
 
 51 
[Rat]     VKESSFVEKMKKTGRNIIVFYGSQTGTAEEFANRLSKDAHRYGMRGMSADPEEYDLADLS  123 
          V+ESSFVEKMKKTGRNIIVFYGSQTGTAEEFANRLSKDAHRYGMRGMSADPEEYDLADLS 
[Human]   VRESSFVEKMKKTGRNIIVFYGSQTGTAEEFANRLSKDAHRYGMRGMSADPEEYDLADLS  126 
 
[Rat]     SLPEIDKSLVVFCMATYGEGDPTDNAQDFYDWLQETDVDLTGVKFAVFGLGNKTYEHFNA  183 
          SLPEID +LVVFCMATYGEGDPTDNAQDFYDWLQETDVDL+GVKFAVFGLGNKTYEHFNA 
[Human]   SLPEIDNALVVFCMATYGEGDPTDNAQDFYDWLQETDVDLSGVKFAVFGLGNKTYEHFNA  186 
 
[Rat]     MGKYVDQRLEQLGAQRIFELGLGDDDGNLEEDFITWREQFWPAVCEFFGVEATGEESSIR  243 
          MGKYVD+RLEQLGAQRIFELGLGDDDGNLEEDFITWREQFWPAVCE FGVEATGEESSIR 






Identities = 164/170 (96%), Positives = 168/170 (98%), Gaps = 0/170 (0%) 
 
Figure 19:  Amino acid alignment of Rattus norvegicus (rat) and Homo sapiens (human) FBD.  
The two sequences share 96% of amino acids, and 98% of positions are identical or contain a 
conservative mutation.  Glycine 141 is highlighted, notice that it falls within a long stretch of 







































Figure 20:  Diagram of the midpoint potentials in wild type and G141T CPR.  
Notice that the G141T mutation caused a change in the relative stabilities of the two 
midpoint potentials for the FMN cofactor.  Midpoint potentials for FAD cofactor of 
G141T CPR are assumed to be the same as wild type because Munro et al. [31] 
demonstrated that the flavin cofactors have the same midpoint potentials in the 




CPR Redox Titrations:  The G141T CPR mutant exhibited unique spectral characteristics 
upon reduction with sodium dithionite (figure 21).  Although the locations of the spectral 
changes upon reduction with sodium dithionite were quite similar to wild type CPR, the 
magnitude of such changes were different (figure 22).  A normalized comparison of the 
reductive titrations of wild type and G141T CPR shows that G141T CPR has an 
absorbance maximum at 581 nm that is less than 75% of the wild type value, indicating 
that less semiquinone is present at thermodynamic equilibrium.  The substantial loss of 
semiquinone state in the reductive titration of G141T FBD confirms that the FBD, not the 
FAD-binding domain, is responsible for the majority of semiquinone state lost in the 
reductive titration of G141T CPR.  Furthermore, this absorbance maximum at 581 nm for 
G141T CPR occurs once three equivalents of electrons have been added (full reduction 
requires four equivalents of electrons) while the absorbance maximum at 581 nm for wild 
type occurs between one and two electron equivalents.  
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Figure 21:  Spectral properties of G141T CPR during redox titration.  G141T CPR 
(5.4 uM) was reduced in a stepwise manner by addition of substoichiometric volumes 
of sodium dithionite (2 mM).  After each addition of sodium dithionite, the system 
was allowed to fully equilibrate before the final spectrum was recorded.  Experiment 
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Figure 22:  A comparison of the maximal semiquinone formation of human wild 
type CPR and rat G141T CPR during a redox titration with sodium dithionite.  
Absorbance at 581 nm is a measure of the amount of flavin cofactor in the 
semiquinone state.  G141T CPR titration was performed at 25° C in 270 mM 
potassium phosphate, pH 7.7.  Wild type data was calculated from reference 31 and 





 When the titration is repeated with NADPH, a complex equilibration reaction 
occurs wherein full reduction of the flavin cofactors is not achieved, even in the presence 
of excess NADPH (figure 23) [45].  Regardless of the reducing agent used, G141T CPR 
still forms 25% less semiquinone than wild type CPR.  Since G141T FBD has 70% less 
semiquinone state at thermodynamic equilibrium than wild type FBD, and G141T CPR 
has only 25% less semiquinone state at thermodynamic equilibrium than wild type CPR, 
it can be concluded that the vast majority of semiquinone state lost at thermodynamic 
equilibrium of G141T CPR results from reduced semiquinone formation of the FMN 
cofactor. 
 After reduction by sodium dithionite, an oxidative titration was performed on the 
fully reduced G141T CPR (figure 24).  Results indicate that the reduction of CPR by 
sodium dithionite is completely reversible.  Once again, G141T CPR formed 25% less 
semiquinone than did wild type CPR.  Maximal semiquinone formation occurred when 
three equivalents of electrons had been removed from CPR.  Recall that for the reductive 
titration maximal semiquinone formation occurred when three equivalents of electrons 
had been added. 
 57 
 
G141T Reductive Titration with NADPH
Wavelength (nm)





















Figure 23:  Spectral properties of G141T CPR during redox titration with the 
physiological reductant NADPH.  Arrows point to the spectrum recorded when 5 
equivalents of NADPH had been added to the system.  Full reduction of CPR should 
require 2 equivalents of NADPH, however at 5 equivalents the band at 580 nm is 
still at a maximal level, indicating that a significant fraction of the flavin cofactors 
are still in the semiquinone state.  G141T CPR (5.4 uM) was reduced in a stepwise 
manner by addition of substoichiometric volumes of NADPH (490 uM).  After each 
addition of NADPH, the system was allowed to fully equilibrate before the final 
spectrum was recorded.  Experiment performed at 25° C in 270 mM potassium 
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Figure 24:  Comparison of maximum semiquinone formation during reductive titration 
of G141T CPR (5.4 uM) by sodium dithionite (2 mM) and then subsequent oxidative 
titration by potassium ferricyanide (0.5 mM).  Absorbance at 580 nm is a measure of the 
amount of flavin cofactor in the semiquinone state.  Experiment performed at 25° C in 
270 mM potassium phosphate, pH 7.7. 
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CPR Steady-State Kinetics:  Given the reduced semiquinone formation and the inversion 
of the relative midpoint potentials of the FMN cofactor for the G141T mutant, and the 
fact that wild type CPR utilizes the FMN semiquinone as the primary electron donor to 
cytochrome c, the effect of the G141T mutation on catalytic activity was probed by 
steady-state kinetic assays.  The cytochrome c reductase assay is a well-established assay 
to measure the overall electron transfer ability of CPR to the non-physiological receptor 
cytochrome c [53, 54, 60, 61].  In this assay, the electrons must travel from NADPH to 
the FAD cofactor and then on to the FMN cofactor before being transferred to 
cytochrome c.  The reduction of cytochrome c is monitored spectrophotometrically at 550 
nm.  Assays were performed with standard solutions of CPR and then repeated after the 
CPR solutions had incubated on ice for one to three hours with a 20-fold molar excess of 
FMN cofactor.  The FMN cofactor was added to test for cofactor dissociation caused by 
the mutation or storage at   -80° C. 
As shown by the data in table 2, there was a 10% increase in activity for the 
G141T CPR mutant upon addition of excess FMN cofactor, indicating that there was a 
small amount of apoprotein present.  However, when this assay was performed again at a 
later date, the addition of excess FMN cofactor caused a 50% drop in activity.  We 
currently have no explanation for this observation.  Upon addition of excess FMN 
cofactor to the wild type stock solution, a 20% increase in activity was observed.  Our 
wild type data without excess FMN cofactor matched well with previously reported data 
[54].  The activity of G141T CPR without excess FMN is only 70% of the wild type 
CPR, indicating that the G141T mutation has affected the overall ability of CPR to 
transfer electrons in a physiological manner. 
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CPR Steady State Turnover Assays 
Sample Activity 
 TN (min^-1) %WT 
WT CPR to Cytochrome c 3920 100 
WT CPR to Cytochrome c (Literature: ref 53) 3900 -- 
G141T CPR to Cytochrome c 2800 71 
WT CPR to Cytochrome c + 20x FMN 6600* (100) 
G141T CPR to Cytochrome c + 20x FMN 3100* (47) 
   
WT CPR to Ferricyanide 6600 100 
WT  CPR to Ferricyanide (Literature: ref 53) 7800 -- 
G141T CPR to Ferricyanide 4000 61 
WT CPR to Ferricyanide + 20x FMN 7000 100 













Table 2:  Steady state turnover assays with wild type and G141T CPR.  Cytochrome c assays 
were performed with 100 uM NADPH, 65 uM cytochrome c and CPR concentrations ranging 
from 1.15 to 15 nM.  Ferricyanide assays were performed with 100 uM NADPH, 500 uM 
potassium ferricyanide, and CPR concentrations ranging from 1.15 to 21 nM.  Where 
indicated, samples were incubated on ice for 1 to 3 hours with a 20-fold excess of free FMN.  
Assays were performed at 25° C in 270 mM potassium phosphate, pH 7.7.  
*Note:  The activity for wild-type CPR was unusually high in the presence of excess FMN.  
Excess FMN was added in an effort to insure that the FMN binding domain was saturated 
with the cofactor.  However, highly variable results were obtained when doing so.  Attempts 
to reproduce the result with a different preparation of CPR resulted in substantially lower 
values both the wild type (2400 to 2800 [+FMN] min-1) and the mutant (~1000 min-1).  In 
contrast, the ferricyanide reductase activities were much less sensitive to added FMN 
suggesting that FMN may be interfering with the cytochrome c reductase assay.  The 
activities of the mutant were consistently less than wild type under all assay conditions, 
however.  Given the variability in the presence of excess FMN and our inability to adequately 
establish an explanation for this phenomenon, comparisons to the steady-state turnover 
activities in the “Results” section will be referenced to the values obtained in the absence of 
FMN which, for wild type, compare favorably to the established literature values obtained 
under similar assay conditions. 
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A ferricyanide reductase activity assay was performed under steady state 
conditions to probe the electron transfer activity of G141T CPR.  Ferricyanide is capable 
of accepting electrons from the FAD cofactor and thus is best suited for probing the 
ability of CPR to accept electrons from NADPH [54].  Assays were performed with 
standard solutions of CPR and then repeated after the CPR solutions had incubated on ice 
for one to three hours with a 20-fold molar excess of FMN cofactor as described above.  
There was a 6% increase in activity of the wild type CPR in the presence of a 20-fold 
excess of FMN cofactor.  Our wild type data with excess FMN cofactor matched well 
with previously reported data [54].   There was a 10% drop in activity of G141T CPR in 
the presence of FMN.  We currently have no viable explanation for this observation.  
G141T CPR had only 65% of the activity of the wild type CPR. Even though the glycine 
to threonine mutation is in the FMN binding domain, it has an effect on the ability of the 
FAD domain to accept electrons from NADPH. 
FBD Pre-Steady-State Reduction Kinetics:  Since the glycine to threonine mutation 
affected the steady-state kinetics of CPR, the pre-steady-state reduction kinetics of the 
FBD were monitored to better understand which step(s) in the catalytic cycle is/are 
affected by the mutation.  The kinetics of electron transfer were measured using a Hi-
Tech Scientific Model SF-61 stopped flow spectrophotometer (table 3).   
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Redox Kinetics for WT and G141T FBD 
     
Sample Transition λ  k 
WT OX-HQ 455  0.008 +/- 0.001 
G141T OX-HQ 455  0.010 +/- 0.001 
     
WT OX-HQ 581  0.004 +/- 0.006 
G141T OX-HQ 581  0.004 +/- 0.004 
     
WT SQ-HQ 455  0.57 +/- 0.21 
G141T SQ-HQ 455  ND* 
     
WT SQ-HQ 581  0.55 +/- 0.04 
G141T SQ-HQ 581  6.6 +/- 2.2 
     
WT HQ-OX 581  8.4 +/- 2.2 










Table 3:  Pre-steady state kinetics of redox transitions of wild type and G141T FBD.  
Formation or loss of the oxidized state was measured at 455 nm while the semiquinone state 
was monitored at 581 nm.  For the OX to HQ transition, FBD with fully oxidized FMN 
cofactor was mixed against a 20-fold excess of sodium dithionite.  For the SQ to HQ 
transition, the FMN cofactor was pre-reduced with sodium dithionite until maximum 
semiquinone formation was achieved.  The FBD with the pre-reduced FMN cofactor was then 
mixed against a 20-fold excess of sodium dithionite.  For the HQ to OX transition, the FMN 
cofactor was pre-reduced to the hydroquinone state with sodium dithionite.  The FBD with the 
pre-reduced FMN cofactor was mixed against a 20-fold excess of potassium ferricyanide.  All 
experiments were performed in 270 mM potassium phosphate, pH 7.7. 
 
* Due to the low formation of semiquinone state in the G141T mutant, most of the absorbance 
change observed at this wavelength is due to the OX – SQ transition rather than the SQ – HQ 
transition, so an appropriate rate could not be assigned. 
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In the first set of experiments, FBD was mixed with a 20-fold excess of sodium dithionite 
to achieve full reduction of the FMN cofactor under pseudo-first order conditions.  
Absorbance changes were monitored at 455 nm to observe the loss of the oxidized state 
and also at 581 nm to observe the formation and loss of the semiquinone state.  Wild type 
and G141T FBD both exhibited slow rates of reduction at 455 nm (0.0084 s-1 and 0.0095 
s-1 respectively) (figure 25 a, c).  This rate is surprisingly slow considering that steady-
state turnover assays with NADPH as the reductant, suggest a rate limiting step of 65 s-1 
[54].  It is also surprising that there is no difference between wild type and G141T in the 
rates of reduction of the flavin cofactors.  
At 581 nm there is no observable change in absorbance, indicating that there is no 
buildup of the semiquinone form of the FMN cofactor (figure 25 b, d).  Since sodium 
dithionite is an obligate one-electron donor, the formation and the reduction of the FMN 
semiquinone must occur as two discrete steps, yet the formation and reduction of the 
FMN semiquinone are not observable. Furthermore, the data from 455 nm could be fit 
with a single exponential equation 5a even though both transitions from oxidized to 
semiquinone and from semiquinone to hydroquinone cause a decrease in absorbance at 
455 nm.  A viable explanation for these observations is that the two transitions occur at 
different kinetic rates, with the second step occurring much faster than the first step.  
Thus, any semiquinone that is formed is quickly converted to hydroquinone, eliminating 
the absorbance changes at 581 nm.  This would make the formation of the semiquinone 
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Figure 25:  Pre-steady-state reduction kinetics of fully oxidized FMN cofactor in wild type 
and G141T FBD by a 20-fold excess of sodium dithionite.  (A)  Wild type FBD monitored 
at 455 nm to observe loss of oxidized state.  Data was fit with a single exponential equation 
with k1 = 0.0084 s-1.  (B)  Wild type FBD monitored at 581 nm to observe formation and 
loss of semiquinone state.  (C)  G141T FBD monitored at 455 nm.  Data was fit with a 
single exponential equation with k1 = 0.0095 s-1.  (D)  G141T FBD monitored at 581 nm.  
All experiments were performed at 25° C in 270 mM potassium phosphate, pH 7.7. 
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 To test this hypothesis, the FBD was titrated with sodium dithionite until 
maximum semiquinone formation was achieved, at which point the solution was 
transferred anaerobically to the stopped flow instrument where it was mixed against a 20-
fold excess of sodium dithionite as before.  Absorbance changes were again monitored at 
455 nm (figure 26 a, c).  At 455 nm, the data could be fit to a single exponential equation 
5a.  The wild type rate was 0.57 s-1, almost two orders of magnitude faster than the 
oxidized to hydroquinone transition.  This confirms the hypothesis of why only one phase 
was observed at 455 nm for the oxidized to hydroquinone transition.  When G141T FBD 
was pre-reduced with sodium dithionite by one electron equivalent, a rate of 0.018 s-1 was 
observed at 455 nm.  This rate is only twice as fast as the oxidized to hydroquinone 
transition and is more than an order of magnitude slower than the wild type data. 
 Absorbance changes were also monitored at 581 nm (figure 26 b, d).  Since there 
is only one possible transition (semiquinone to hydroquinone) the absorbance changes 
from both 455 nm and 581 nm report on the same electron transfer event and thus should 
give consistent rates.  Wild type FBD conformed with this hypothesis with a rate of 0.55 
s-1 at 581 nm compared to a rate of 0.57 s-1 at 455 nm.  G141T FBD had different rates at 
455 nm (0.018 s-1) and 581 nm (6.6 s-1).  What can account for such a difference in rates?  
Recall that during the reductive titration of G141T FBD that even when one electron 
equivalent had been added, the majority of the FMN cofactors in solution existed either 
the oxidized or semiquinone state.  Thus, for G141T FBD, even when maximal 
semiquinone formation is achieved, the majority of the absorbance changes at 455 nm are 
due to the reduction of the oxidized flavin rather than the semiquinone, thereby 











Figure 26:  Pre-steady-state reduction kinetics of wild type and G141T FBD by a 20-fold excess of 
sodium dithionite where the FMN cofactor had been pre-reduced to maximum semiquinone 
formation by sodium dithionite.  (A)  Wild type FBD monitored at 455 nm to observe loss of 
oxidized state.  Data was fit with a single exponential equation with k1 = 0.57 s-1.  (B)  Wild type 
FBD monitored at 581 nm to observe formation and loss of semiquinone state.  Data was fit with a 
single exponential equation with k1 = 0.55 s-1.  (C)  G141T FBD monitored at 455 nm.  Data was fit 
with a single exponential equation with k1 = 0.018 s-1.  Due to the low formation of semiquinone 
state in the G141T mutant, most of the absorbance change observed at this wavelength is due to the 
OX – SQ transition rather than the SQ – HQ transition.  (D)  G141T FBD monitored at 581 nm.  
Data was fit with a single exponential equation with k1 = 6.6 s-1.  All experiments were performed 
at 25° C in 270 mM potassium phosphate, pH 7.7. 
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 The observed rate of 6.6 s-1 for the semiquinone to hydroquinone transition for 
G141T FBD is significantly faster than the observed transition from oxidized FMN to 
hydroquinone FMN (0.0095 s-1), which is consistent with the proposed explanation for 
the observation of a single phase at 455 nm for the oxidized to hydroquinone transition.  
The semiquinone to hydroquinone transition observed in G141T FBD is also an order of 
magnitude faster than the same transition in wild type FBD (0.55 s-1).  This difference in 
rates between wild type and G141T FBD is difficult to explain directly at the molecular 
level.  Many factors control electron transfer rates, especially using non-physiologic 
reductants such as sodium dithionite as used in these experiments.  However the faster 
reduction rate for the SQ in G141T FBD is consistent with the substantial decrease in the 
midpoint potentials for the OX/SQ couple reflecting the lower stability of the SQ state in 
this mutant.  Thus, it might be expected that the reduction of the semiquinone to 
hydroquinone, would occur faster in G141T FBD than wild type FBD (figure 20).   
 With the rates of reduction of the FMN cofactor of the FBD well characterized, 
the rates of oxidation were measured.  In this experiment, FBD was titrated with sodium 
dithionite until the FMN cofactor was fully converted to the hydroquinone form.  Care 
was taken so as not to add excess sodium dithionite to the solution.  The fully reduced 
FBD was then transferred anaerobically to the stopped-flow instrument and rapidly 
mixed with a 20-fold excess of potassium ferricyanide.  Absorbance changes were 
monitored at 455 nm and 581 nm.  There is good agreement in the rates of oxidation 
observed at 455 nm and 581 nm for both wild type (6.7 s-1 and 8.4 s-1 respectively) and 
for G141T FBD (26.7 s-1and 26.8 s-1) (figure 27).  Figures 27b and 27d show the traces 
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Figure 27:  Pre-steady-state oxidation kinetics of wild type and G141T FBD by a 20-fold 
excess of potassium ferricyanide where the FMN cofactor had been pre-reduced to the 
hydroquinone state by sodium dithionite.  (A)  Wild type FBD monitored at 455 nm to 
observe formation of oxidized state.  Data was fit with a single exponential equation with k1 
= 6.7 s-1.  (B)  Wild type FBD monitored at 581 nm to observe formation and loss of 
semiquinone state.  Data was fit with a single exponential equation with k1 = 8.4 s-1.  (C)  
G141T FBD monitored at 455 nm.  Data was fit with a single exponential equation with k1 
= 26.7 s-1.  (D)  G141T FBD monitored at 581 nm.  Data was fit with a single exponential 
equation with k1 = 26.8 s-1.    For both wild type and G141T FBD at 581 nm, only one phase 
is observed, corresponding to the loss of semiquinone state.  All experiments were 
performed at 25° C in 270 mM potassium phosphate, pH 7.7.   
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It is interesting to note that both traces can be fit with a single exponential equation 5a.  
Potassium ferricyanide can only accept one electron, so two distinct phases are expected, 
correlating to the formation of the semiquinone and its subsequent oxidation.  The only 
phase that is observed is the oxidation of the semiquinone to the oxidized state, indicating 
that the oxidation of the hydroquinone to the semiquinone state occurs within the dead 
time of the instrument (1 ms).   
The data shows that G141T FBD donates electrons to potassium ferricyanide 
three to four times faster than wild type FBD.  This is a somewhat unexpected result in 
light of the steady-state turnover data.  Although it should be pointed out that the 
ferricyanide assay performed on CPR was used to measure the rate of electron transfer 
from the FAD-binding domain, not the FBD.  Additionally, potassium ferricyanide is a 
chemical oxidant, while cytochrome c is a protein.  The interaction between cytochrome 
c and FBD may be quite different than the interaction between potassium ferricyanide 
and FBD.  Still, these experiments provide insight into the effect of the glycine to 
threonine mutation.  Recall that measurement of the midpoint potentials of the FMN 
cofactor of the FBD showed that the OX/SQ midpoint potential had been decreased by 
over 200 mV.  With the semiquinone state in G141T FBD significantly destabilized, it is 
a better reductant and thus it will reduce potassium ferricyanide faster. 
CPR Pre-Steady-State Reduction Kinetics:  The pre-steady-state reduction kinetics of the 
FBD showed all measurable transitions to occur faster in the G141T mutant than in wild 
type.  The pre-steady-state reduction kinetics of G141T CPR were determined for all 
measurable transitions (table 4) to more thoroughly dissect how the mutation affected the 
mechanism of electron transfer.     
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Pre-Steady-State Reduction Kinetics of CPR 
       
Sample Transition [DT] λ  k1   k2 
G141T OX-HQ 20x 581 0.023 +/- 0.002  0.018 +/- 0.002 
       
       
Sample Transition [NADPH] λ  k1   k2 
WT* OX-HQ 15x 450 20  3.7 
G141T OX-HQ 15x 455 113 +/- 54  12.5 +/- 2.1 
       
WT* OX-HQ 15x 600 20  3.5 
G141T OX-HQ 15x 581 51 +/- 5  9.5 +/- 0.9 
       
G141T 4°C@ OX-HQ 15x 455 2.7  0.013 
    0.3   
G141T 4°C OX-HQ 15x 581 3.6 +/- 1.5  0.042 +/- 0.033 
       
WT* OX-SQ 1 to 1 581 20  0 
G141T # OX-SQ 1 to 1 581 69 +/- 7  0.014 
    2.1 +/- 0.06   









Table 4:  Pre-steady-state reduction kinetics of CPR.  Absorbance changes were measured at 455 
nm to observe reduction of oxidized state and 581 or 600 nm to observe formation and loss of the 
semiquinone state.  G141T data was collected at 25° C in 100 mM potassium phosphate, pH 7.0.  
Wild type values are from reference 42 and are based on human CPR, rather than rat CPR.  Wild 
type data was collected at 25° C in 50 mM potassium phosphate, pH 7.0. 
 
@ G141T CPR 4° could be fit by a triple exponential equation. The first two phases, k1 = 2.7 s-1, 
k2 = 0.3 s-1, correspond with a decrease in absorbance at 455 nm.  The third phase, k3 = 0.013 s-1, 
corresponds with an increase in absorbance at 455 nm. 
 
# G141T CPR mixed with a 1 to 1 solution of NADPH was fit with a three exponential equation.  
The first two phases, k1 = 69 s-1, k2 = 2.1 s-1, correspond with an increase in absorbance at 581 
nm.  The third phase, k3 = 0.014 s-1, corresponds with a decrease in absorbance at 581 nm. 
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In the first experiment G141T CPR was mixed with a 20-fold molar excess of sodium 
dithionite to draw comparisons with the pre-steady-state reduction kinetics of the FBD.  
Two distinct phases were observed at 581 nm, the first correlating with the formation of a 
flavin semiquinone and the second with the reduction of the semiquinone to a 
hydroquinone (figure 28).  However, both transitions were quite slow (k1 = 0.023 s-1, k2 = 
0.018 s-1), especially when compared to the SQ to HQ transition for the FBD (k = 6.6 s-1).    
The rates for the formation and reduction of the semiquinone state were quite similar, so 
whenever any semiquinone state was formed, it reduced to the hydroquinone state at 
almost the same speed.  This explains why the absorbance change at 581 nm was only 
10% of what was expected.  Sodium dithionite can reduce both flavin cofactors directly 
and the two flavin cofactors are essentially indistinguishable in a stopped-flow 
experiment, so we were unable to determine which flavin was contributing to the 
absorbance changes at 581 nm.  Because of these results, all future experiments were 
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Figure 28:  Pre-steady-state reduction of G141T CPR by a 20-fold excess of sodium 
dithionite, monitored at 581 nm.  The trace could be fit by a double exponential equation 
with k1= 0.023 s-1 and k2= 0.018 s-1 correlating to the formation and then reduction of the 
semiquinone state of the flavin cofactors.  Because the rates for the formation and the 
reduction of the flavin cofactors are so close together, the absorbance change at 581 nm is 
only 10% of what was expected.  Experiment was performed at 25° C in 100 mM 
potassium phosphate, pH 7.0. 
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 NADPH is an obligate two-electron donor, so the oxidation of one molecule of 
NADPH by CPR leads to three possible redox states FAD HQ – FMN OX, FAD SQ –
FMN SQ, and FAD OX – FMN HQ (figure 9).  The oxidation of a second molecule of 
NADPH by CPR leads to full reduction of both flavin cofactors.  Two distinct phases are 
observed at 581 nm upon reduction of G141T CPR with a 15-fold molar excess of 
NADPH (figure 29c).  The first phase shows an increase in absorbance, indicating that 
two electrons had been transferred from NADPH to G141T CPR to form the 
disemiquinoid species while the second phase shows a drop in absorbance, correlating 
with the transfer of a second pair of electrons from NADPH to G141T CPR, reducing 
both flavin cofactors to the hydroquinone.  The rates for these two phases are 51 s-1 and 
9.5 s-1 respectively.  Previously published results for the reduction of wild type CPR with 
a 20-fold excess of NADPH also showed two distinct phases.  However, the rates for 
these two phases (20 s-1 and 3.5 s-1) were approximately half the rates observed for 
G141T CPR [42].  It is interesting to note that the rate of reduction of the G141T CPR 
disemiquinoid state (k2 = 9.5 s-1) is comparable to the SQ to HQ transition for the G141T 
FBD (k1 = 6.6 s-1).  Although caution must be used in this comparison due to the multiple 
flavin cofactors in CPR and the different nature of the reductants used.  Upon observation 
at 581 nm for an extended period of time, one to eight minutes, a third phase is observed 
with complex kinetics wherein the absorbance at 581 nm increases (figure 29d).  This is 
most likely due to equilibration of the flavin cofactors with NADPH/NADP+ [45].  Due 
to the extended time scale needed to observe this phase, it is not physiologically relevant 
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Figure 29:  Pre-steady-state reduction of G141T CPR by a 15-fold excess of NADPH.  
All experiments were performed at 25° C in 100 mM potassium phosphate, pH 7.0.  (A)  
Absorbance changes monitored at 455 nm over a physiologically relevant time period of 
2 s.  The data can be fit by a double exponential equation with k1 = 113 s-1 and k2 = 12.5 
s-1.  (B)  When the observation period at 455 nm is extended out past 5 minutes, no 
additional phases were absorbed.  (C)  When absorbance values are monitored at 581 
nm over a physiologically relevant time period of 2 s, the data can be fit by a double 
exponential equation with k1 = 51 s-1 and k2 = 9.5 s-1.  (D) When the observation period 
at 581 nm is extended out past 5 minutes, a third phase is observed.  This increase in 






 Interestingly, the pre-steady-state reduction experiments conducted on human 
wild type CPR with a 20-fold excess of NADPH by Gutierrez et al. showed two phases 
with nearly identical rates when the absorbance changes were monitored at 455 nm and 
581 nm (20 s-1, 3.7 s-1, and 20 s-1, 3.5 s-1 respectively) [42].  However, absorbance 
changes at 455 nm monitor reduction of the oxidized flavins while changes at 581 nm 
monitor formation and reduction of the semiquinone state.  Transfer of the hydride ion 
from NADPH to FAD should cause a loss of absorbance at 455 nm but should not affect 
absorbance at 581 nm.  The subsequent transfer of an electron from FAD HQ to the FMN 
cofactor to the form the disemiquinoid state will cause the absorbance at 581 nm to 
increase.  Finally, the transfer of a second hydride ion from NADPH will form the FAD 
HQ – FMN HQ and cause a drop in absorbance at both 455 nm and 581 nm.  If there are 
three different transitions, why are only two rates observed, and why does k1 at 455 nm 
match k1 at 581 nm?  Figure 30 provides a possible explanation.  The transfer of an 
electron from FAD HQ to the FMN OX to form FAD SQ – FMN SQ occurs significantly 
faster than transfer of a hydride ion from NADPH to FAD OX, thus causing the first two 
transitions to appear as one event.  When the standard deviations are taken into account 
for G141T CPR, k1 at 581 nm and k1 at 455 nm are very similar, suggesting that the 















































51 s-1 Fast 9.5 s-1 
NADPH NADP+ 
G141T CPR 
Figure 30:  A schematic comparison of the pre-steady-state reduction kinetics of wild 
type and G141T CPR with a 20-fold and 15-fold excess of NADPH respectively.  Wild 
type data is from reference 42.  The increase in absorbance at 581 nm is due to the 
formation of the disemiquinoid state.  Transfer of the hydride ion from NADPH to the 
FAD cofactor is rate limiting step in the formation of the disemiquinoid species.   
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 The above experiment was then repeated except the temperature was dropped to 
4° C with the hypothesis that interflavin electron transfer is more temperature sensitive 
than reduction by NADPH.  Thus, dropping the temperature to 4° C could allow for the 
observation of CPR going from FAD HQ – FMN OX to FAD SQ – FMN SQ [45, 62].  
Lowering the temperature did change the kinetics of the reaction, significantly decreasing 
all observable rates (table 4) (figure 31).  At 581 nm two phases were observed, except 
this time both phases showed an increase in absorbance at 581 nm.  Since NADPH is an 
obligate two-electron donor to the FAD cofactor, the only way to increase the absorbance 
at 581 nm is to go from the FAD hydroquinone to the disemiquinoid species.  Unless a 
series of complex inter-protein electron transfers are occurring, we currently have no 
viable explanation for a biphasic increase in absorbance at 581 nm.  Attempts to clarify 
this issue by monitoring the reduction of G141T CPR with a stoichiometric solution of 
NADPH at 4° C failed because the lower concentration of NADPH and the lower 
temperatures combined to make the signal to noise ratio too low.  The data at 455 nm was 
triphasic with the first two rates corresponding to a decrease in absorbance at 455 nm (k1 
= 2.7 s-1, k2 = 0.3 s-1).  The first rate at 455 nm matches the first rate at 581 nm (k1 = 3.6 
s-1), while the third rate at 455 nm (k3 = 0.013 s-1) corresponds with the second rate 












Pre-Steady-State Reduction Kinetics of G141T CPR
with 15-Fold Excess of NADPH at 4° C.
Time (s)
















Pre-Steady-State Reduction Kinetics of G141T CPR at 4° C
With a 15-Fold Excess of NADPH
Time (s)


















Figure 31:  Pre-steady-state reduction kinetics of G141T CPR with a 15-fold excess of 
NADPH.  (A) Absorbance changes at 455 nm could be fit by a triple exponential equation 
with k1 = 2.7 s-1 and k2 = 0.3 s-1, k3 = 0.013 s-1.  The first two rates describe the decrease in 
absorbance while the third rate describes the increase in absorbance.  (B) Absorbance changes 
at 581 nm could also be fit by a double exponential equation with k1 = 3.6 s-1 and k2 = 0.04 s-
1.  Both experiments were conducted at 4° C in 100 mM potassium phosphate pH 7.0.   
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 The pre-steady state kinetics for the reduction G141T CPR at 25° C by a 
stoichiometric amount of NADPH were then measured.  This time, three rates were 
observed at 581 nm (figure 32).  The first two rates (69 s-1 and 2.1 s-1) correspond with an 
increase in absorbance at 581 nm, thus they monitor the formation of the semiquinone 
state.  Since NADPH is an obligate 2 electron donor and the only way to form the 
semiquinone state in CPR is to go from FAD HQ – FMN OX to FAD SQ – FMN SQ, we 
have no explanation for why two rates are observed corresponding to an increase in 
semiquinone formation.  Even though this experiment was performed with a 
stoichiometric amount of NADPH rather than a 15-fold excess, which creates pseudo first 
order conditions, the first observed rate for the stoichiometric NADPH (69 s-1) matched 
well with the 15-fold excess NADPH data (51 s-1).  This indicates that the reductase is 
saturated with reduced pyridine nucleotide at a very rapid rate, much faster than hydride 
transfer to the FAD [45].  The G141T CPR data differs from previously published results 
for wild type CPR, which show that the reduction of wild type CPR by a stoichiometric 
amount of NADPH is essentially monophasic with a rate of 20 s-1 (figure 33) [42].  The 
single phase observed for wild type CPR corresponds with the formation of the 
disemiquinoid species as do the first two phases in G141T CPR, while the third phase 
observed for G141T CPR corresponds with the reduction of the disemiquinoid species.  
Although the transition from the disemiquinoid species to FAD OX – FMN HQ was very 
slow, the fact that it did eventually occur in G141T CPR and not wild type CPR is easy to 
rationalize given the inversion of the relative midpoint potentials of the FMN cofactor in 
the G141T mutant. 
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Figure 32:  Pre-steady-state reduction kinetics of rat G141T CPR by a 
stoichiometric amount of NADPH.  Abosrbance changes monitored at 581 nm on a 
logarithmic time scale.  The data was fitted with a triple exponential equation with 
k1 = 69 s-1, k2 = 2.1 s-1, k3 = 0.014 s-1.  Time scale is extended to show the eventual 
decrease in absorbance corresponding with the transition from FAD SQ – FMN SQ 
to FAD OX – FMN HQ.  Reaction was performed at 25° C in 100 mM potassium 
phosphate, pH 7.0.   
 
























Figure 33: Pre-steady-state reduction kinetics of human wild type CPR by NADPH, observed 
on a linear time scale. Ratios indicate relative concentrations of CPR and NADPH. (A)  
Absorbance changes monitored at 450 nm to observe reduction of the oxidized state of the 
flavin cofactor.  Human, wild type CPR was mixed against a 20-fold excess of NADPH.  The 
data could be fit by a double exponential equation with k1 = 20 s-1 and k2 = 3.5 s-1.  (B)  
Absorbance changes monitored at 600 nm to observe formation and reduction of the 
semiquinone state of the flavin cofactor.  For the transient shown with a 20:1 ratio of 
NADPH/CPR, the data was fitted with a double exponential equation yielding values for K1 
and k2 of 20 and 3.5 s-1, respectively.  For the transients with a 1:1 ratio of NADPH/CPR the 
data was fitted with a single exponential equation with k1 = 20 s-1.  Reactions performed at 
25° C in 50 mM potassium phosphate buffer, pH 7.0. [CPR] 10 uM, [NADPH] 200 uM.  Wild 
type data from reference 42. 
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FBD Single Turnover Assay:  With all transitions in G141T CPR and FBD faster 
than wild type, but the steady-state turnover data suggesting that G141T CPR is less 
catalytically efficient than wild type CPR, a series of experiments were performed to 
measure the kinetics of electron transfer from FBD to cytochrome c (table 5).  The rate of 
electron transfer from FBD to the oxidant potassium ferricyanide had already been 
measured, however, potassium ferricyanide is a non-physiological chemical oxidant and 
may interact with the FBD in a different manner than cytochrome c.  In the first 
experiment, sodium dithionite was titrated into a solution of wild type FBD until the 
FMN cofactor was fully reduced.  Care was taken so that excess sodium dithionite was 
not added.  The solution was transferred anerobically to the stopped flow instrument 
where it was rapidly mixed with a 7-fold excess of cytochrome c with absorbance 
changes monitored at 550 nm to follow the reduction of cytochrome c (figure 34a).  The 
resulting data had a low signal to noise ratio, but was fit with a double exponential 
equation 5b with the first phase tracing an increase in absorbance at 550 nm and the 
second phase tracing a decrease in absorbance at 550 nm.  An increase in absorbance at 
550 nm corresponds with the reduction of cytochrome c, so the only way for the 
absorbance at 550 nm to decrease would be for cytochrome c to become oxidized.  
Unless there was contamination of free oxygen in the cytochrome c solution, we currently 
have no explanation for these results.  Focusing on the first phase, which traces the 
reduction of cytochrome c, the rate of reduction is significantly slower (0.018 s-1) than the 
steady state turnover data (rate limiting step of 65 s-1), and the reduction of potassium 
ferricyanide (8.3 s-1). 
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Kinetics for Electron Transfer from Wild Type FBD to Cytochrome c 
       
 Transition [Cyt c] K1 (s-1)   K2 (s-1)  
 HQ-OX 7x 0.018 +/- 0.01  0.0025 +/- 0.0019  
       
 HQ-OX 1 to 1 0.005 +/- 0.007    
       
 SQ-OX 7x 0.032 +/- 0.006  0.0037 +/- 0.0041  
       





Table 5:  Single turnover assays for wild type FBD.  The FMN cofactor was pre-
reduced with sodium dithionite to either the hydroquinone state or the semiquinone 
state.  With the flavin cofactor already reduced, the FBD was mixed against either a 
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Single Turnover Assay, Wild Type FBD HQ to Equimolar Cytochrome c
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Figure 34:  Single turnover assay of wild type FBD with the FMN cofactor in the 
hydroquinone state.  The flavin cofactor was pre-reduced to the hydroquinone state by 
sodium dithionite.  Absorbance changes were monitored at 550 nm to observe reduction of 
cytochrome c.  (A)  FBD was mixed against a 7-fold excess of cytochrome c.  The data 
could be fit by a double exponential equation with k1 = 0.018 s-1 and k2 = 0.0025 s-1.  (B) 
FBD was mixed against an equimolar solution of cytochrome c.  The data could be fit by a 
single exponential equation with k1 = 0.005 s-1.  Reactions were performed at 25° C in 100 
mM potassium phosphate, pH 7.0. 
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The experiment was then repeated except this time an equimolar concentration of 
cytochrome c was mixed with fully reduced FBD (figure 34b).  The data from this 
experiment was fit with a single exponential equation 5a.  The rate for this reaction was 
measured at 0.005 s-1, which is about 3.5 times slower than the rate for experiments with 
a seven-fold excess of cytochrome c.  This discrepancy in rates can be attributed to 
concentration effects since a seven-fold excess of cytochrome c creates pseudo first order 
conditions while an equimolar concentration of cytochrome c does not.  These results add 
support to our hypothesis that cytochrome c interacts with the FBD in a different manner 
than the chemical oxidant potassium ferricyanide.  The significantly slower rate of 
electron transfer to cytochrome c, compared to steady state turnover data, raises new 
questions.  Does cytochrome c need to also interact with the FAD-binding domain in 
order for efficient electron transfer to occur?  Does the FAD-binding domain exert an 
influence on the FBD which affects electron transfer to cytochrome c?  What effect does 
the redox state of the FMN cofactor have on the FBD’s ability to transfer electrons to 
cytochrome c? 
 To answer the third question, another experiment was performed wherein wild 
type FBD was titrated with sodium dithionite until maximal semiquinone formation was 
achieved.  The solution was then transferred anaerobically to the stopped-flow instrument 
where it was rapidly mixed with a seven-fold excess of cytochrome c (figure 35a).  As 
with the previous experiment where the FMN cofactor of wild type FBD was pre-reduced 
to the hydroquinone form, the data could be fit with a double exponential equation 5b.  
As previously described, only one phase was expected.  We have no explanation for the 
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Time (s)
















Figure 35:  Single turnover assay of wild type FBD with the FMN cofactor in the 
semiquinone state.  The flavin cofactor was pre-reduced to the semiquinone state by 
sodium dithionite.  Absorbance changes were monitored at 550 nm to observe reduction 
of cytochrome c. (A)  FBD was mixed against a 7-fold excess of cytochrome c.  The data 
could be fit by a double exponential equation with k1 = 0.032 s-1 and k2 = 0.0037 s-1.  (B)  
FBD was mixed against an equimolar solution of cytochrome c.  The data could be fit by a 
single exponential equation with k1 = 0.0074 s-1.  Reactions were performed at 25° C in 
100 mM potassium phosphate, pH 7.0. 
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 Focusing on the first phase of the reaction, the rate of reduction of cytochrome c 
by the FMN semiquinone is 0.032 s-1, which is similar to the rate of reduction by the 
FMN hydroquinone (0.018 s-1).  The experiment was repeated except this time an 
equimolar concentration of cytochrome c was used (figure 35b).  The data conformed 
well with the oxidation of fully reduced, wild type FBD with an equimolar solution of 
cytochrome c (figure 34b).  As with the previous experiment, this data could be fit by a 
single exponential equation 5a with a rate of 0.005 s-1.  Again, this rate is slower than the 
seven-fold excess cytochrome c experiments.  These results indicate that, for the reaction 
of wild type FBD with cytochrome c, the redox state of the flavin cofactor has a minimal 
effect on the rate of electron transfer.  However, the results obtained in this experiment 
directly contradict the work of Grunau et al, which show that rapid mixing of one 
electron reduced human FBD with cytochrome c should give a rate of approximately 3.6 
s-1 [32].  We cannot account for this discrepancy in the rates of reduction of cytochrome 
c.  Given the unexplained phases encountered with the 7-fold excess of cytochrome c and 
our inability to replicate literature results, we believe that there may be a technical error 
with these experiments.  As such, these results are given little weight in determining the 
conclusion. 
CPR Single Turnover Assay:  Given that the rate of electron transfer from the FBD to 
cytochrome c was too slow to be physiologically relevant, the rate of electron transfer 
from CPR to cytochrome c was measured via single turnover assays.  Several different 
approaches were attempted to measure this rate.  In the first approach, G141T CPR was 
pre-reduced with excess NADPH, but due to the equilibration reaction previously 
described, the four-electron reduced state was not formed.  The pre-reduced CPR was 
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then mixed with a 10-fold excess of cytochrome c.  No absorbance changes were 
observed at 550 nm, indicating that G141T CPR was incapable of reducing cytochrome c 
(figure 36a), which is consistent with previous experiments on wild type house fly CPR 
[63].  When the observation period was extended out to over one minute, a decrease in 
absorbance at 550 nm was observed (figure 36 b).  The decrease in absorbance was also 
observed in the FBD single turnover experiments (figures 34a, 35a) and is most likely 
due to an experimental artifact such as light scattering or cytochrome c complex 
formation.   The inability of G141T CPR to donate electrons to cytochrome c after 
incubation with NADPH is likely due to the “third phase” equilibration reaction 
described above where it is proposed that air-stable inactive FMN is kinetically stabilized 
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Series of Spectra Over Time of G141T CPR Pre-Reduced with Sodium Dithionite 
with a 2-Fold Excess of NADP+ Present 
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Figure 36:  Single turnover assay with G141T CPR pre-reduced in the presence of NADP+.  
(A)  G141T CPR was pre-reduced with more than two equivalents of NADPH so that full 
reduction of the flavin cofactors should have been achieved.  The reduced CPR was mixed 
against a 10-fold excess of cytochrome c and absorbance changes were monitored at 550 nm 
to observe reduction of cytochrome c.  Over a physiologically relevant time frame, no 
absorbance changes were observed.  (B)  When the time frame is extended out past 5 
minutes, a decrease in absorbance is observed at 550 nm.  (C)  G141T CPR was mixed with 
a 2-fold excess of NADP+ and the system was fully reduced by sodium dithionite.  The 
reduced G141T CPR was mixed against a 10-fold excess of cytochrome c and a series of 
spectra were taken in the 2 minutes following the mixing of the two proteins.  A clear 
decrease in absorbance at all wavelengths is observed as the observation period is extended. 
But, a more important observation is that no reduced cytochrome c is observed, meaning 
that reduction didn’t take place in the dead time of the stopped-flow.  All experiments were 
performed at 25° C in 100 mM potassium phosphate buffer, pH 7.0. 
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Previous experiments by Grunua et al. indicate that interaction between  
NADPH/NADP+ and CPR is necessary for the FMN binding domain to overcome its 
constrained state and efficiently interact with cytochrome c [32].  To further explore this 
phenomenon, G141T CPR was mixed with an equimolar solution of NADP+ and then 
CPR was reduced with sodium dithionite until maximal semiquinone formation was 
achieved.  The hope was that without NADPH in the solution, the slow equilibration 
reaction between NADPH/NADP+ and the flavin cofactors could not occur and G141T 
CPR would be able to donate electrons to cytochrome c so that the single turnover assay 
could be performed.  However, the literature states that the FAD binding domain of CPR 
is structurally similar to the flavoenzyme ferredoxin-NADP+ reductase (FNR) [15-19]. 
Additionally both fully reduced, isolated FMN binding domain of human CPR [42] and 
fully reduced CPR from pig liver [62] have been shown to reduce NADP+ to NADPH.  
Since there was no data in the literature regarding rat CPR and, of course, the G141T 
mutant, we proceeded with the experiments.  As was suggested by the literature, although 
sodium dithionite is incapable of reducing NADP+ directly, NADP+ was reduced to 
NADPH via the FAD hydroquinone and CPR was made catalytically incompetent by the 
slow equilibration reaction (figure 36c). 
 Since neither of the two previously described methods allowed G141T CPR to 
transfer electrons to cytochrome c, a third assay was attempted.  In this set up one 
equivalent of NADPH is combined with varying solutions of cytochrome c.  This 
NADPH/cytochrome c solution is then mixed against G141T CPR in the stopped flow 
instrument.  G141T CPR had a Kmax of 7.9 s-1 and a Kd of 103 uM while wild type CPR 
had a Kmax of 4.55 s-1 and a Kd of 88 uM (figure 37) (table 6).  The wild type Kmax 
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does not compare well with previously reported values of 14 s-1, and the Kd obtained 
does not match the literature value of 37 uM [32].  It should be noted that experiments 
performed by Grunau et al used 100 mM BES, pH 7.0 while measurements conducted in 
this laboratory were in 100 mM potassium phosphate, pH 7.0.  Since BES is a zwitterion, 
the ionic strength of the buffer is 39 mM while the potassium phosphate buffer has an 
ionic strength of 225 mM, which could account for the difference in Kd [64].  Based on 
pre-steady-state reduction kinetics, it is not surprising that G141T CPR exhibits a Kmax 









Sample Kmax (s-1) Kd (uM) 
WT CPR 4.55 +/- 0.55 88 +/- 29 
G141T CPR 7.90 +/- 0.74 103 +/- 23 
   






Single Turnover Stopped Flow Experiment with G141T CPR
Michaelis Menten Fit Ki = (Kmax*[S])/(Kd+[S])
Kmax = 7.90 +/- 0.74 s^-1    Kd = 103 +/- 23 uM
[Cytochrome c] (uM)





























Single Turnover Stopped Flow Experiment with WT CPR
Michaelis Menten Fit Ki = (Kmax*[S])/(Kd+[S])
Kmax = 4.55 +/- 0.55 s^-1   Kd = 88.28 +/- 28.72 uM
[Cytochrome c] (uM)




























Figure 37:  Single turnover stopped flow experiment on CPR.  (A)  Wild type CPR had a Kmax 
of 4.55 +/- 0.55 s-1 and a Kd of 88 +/- 29 uM.  (B) G141T CPR had a Kmax of 7.90 +/- 0.74 s-1 
and a Kd of 103 +/- 23 uM.  All data was fit using the Michaelis Menten equation (equation 6). 
Reactions were performed at 25° C in 100 mM potassium phosphate, pH 7.0.  A solution of 10 
uM CPR was mixed against a solution with 10 uM NADPH and cytochrome c concentrations 
ranging from 10.5-271 uM. 
 
Single Turnover Summary 
Table 6:  Summary of single turnover stopped flow experiments.  Wild type and G141T 
CPR were performed in 100 mM potassium phosphate, pH 7.0 which has an ionic strength 
of 225 mM.  Literature value comes from reference 32.  Literature reactions were 
performed in 100 mM BES, pH 7.0, which has an ionic strength of 39 mM.  All reactions 
were performed with a 10 uM solution of CPR in syringe A mixed against syringe B 




This study has explored how protein-cofactor interactions modulate the redox 
properties of the bound cofactor flavin mononucleotide (FMN) by focusing on a 
conserved glycine residue (glycine-141) that is thought to form a hydrogen bond to the 
N5H of the reduced flavin through its backbone carbonyl group.  Previous studies on this 
conserved glycine residue in the D. vulgaris and C. beijerinckii flavodoxins have 
demonstrated that this hydrogen bonding interaction helps to stabilize the semiquinone 
state of the FMN cofactor and that insertion of a β-branched amino acid such as valine or 
threonine can significantly interrupt this interaction and change the redox properties of 
the bound flavin cofactor.  This study has extended the results of the flavodoxin studies to 
their mammalian homologue, the FMN domain of CPR, and in so doing has confirmed 
that the conserved glycine residue in the FMN binding loop of CPR plays a crucial role in 
modulating the flavin redox properties.   
The G141T mutation did, in fact, significantly destabilized the semiquinone state 
as is evidenced by its reduced formation during reductive titrations of both CPR and 
FBD.  However, the extent of the semiquinone destabilization was significantly larger 
than expected.  For C. beijerinckii, the glycine to threonine mutation caused the OX/SQ 
midpoint potential to shift from -92 mV to -270 mV and the SQ/HQ midpoint potential to 
shift from -399 mV to -320 mV, a shift of -178 mV and +79 mV respectively [47].  In 
CPR the OX/SQ couple shifted from -43 mV to -250 mV and the SQ/HQ midpoint 
potential shifted from -280 mV to -219 mV, a shift of -207 mV and +60 mV respectively 
(figure 38).  The changes in midpoint potential for CPR were so large that it actually 
switched the relative stabilities of the SQ and HQ state, making the HQ more 
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thermodynamically stable than the SQ for the G141T mutant (Figure 20).  None of the 
glycine mutants in the C. beijerinckii flavodoxin resulted in an inversion of relative 
stabilities of the redox states.  The glycine to valine mutant in the D. vulgaris flavodoxin 
resulted in a decrease in the OX/SQ midpoint potential of 190 mV and an increase in the 
SQ/HQ midpoint potential of 141 mV [46].  Combined, these changes also resulted in an 
inversion of the relative stabilities of the redox states of the FMN cofactor.  However, the 
FMN binding loop in D. vulgaris flavodoxin is significantly larger than the FMN binding 
loop in CPR and analysis of the crystal structures show that mutation of the glycine 
residue significantly alters the contacts between the flavin cofactor and the surrounding 
protein, suggesting that comparisons between CPR and C. beijerinckii are more 
insightful.  Thus, mutation of the conserved glycine residue in the FMN binding loop of 
CPR to a β-branched amino acid results in changes to the midpoint potentials, 
particularly the OX/SQ midpoint potential, of the FMN cofactor that are similar to, but 







Δ mV  
Figure 38:  Change in the OX/SQ and SQ/HQ midpoint potentials upon mutation of the 
conserved glycine residue in the FMN binding loop to a beta-branched amino acid.  For 
D. vulgaris flavodoxin, glycine was mutated to valine [46], while for C. beijerinckii [47] 
and CPR glycine was mutated to threonine. 
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How is this accomplished at the molecular level? X-ray crystallography has 
provided direct structural evidence for a redox-associated conformational change 
involving a rearrangement of the loop containing this glycine residue in the flavodoxins.  
This change results in the “flipping” of the carbonyl group of the glycine, which points 
away from the FMN in the oxidized state, so that it can serve as a hydrogen bond 
acceptor to the N5H of the FMN cofactor in the reduced states.  This newly formed 
hydrogen bond serves to thermodynamically stabilize the neutral SQ state in these 
proteins [47].  Based on the similar destabilization of the neutral FMN SQ in the G141T 
CPR mutant, it is tempting and also reasonable to propose that a conformational change 
analogous to the one found in C. beijerinckii flavodoxin occurs in CPR and that this 
change is crucial in establishing the redox properties and contributes to the overall 
electron transfer mechanism in this reductase.  
Interestingly, the crystal structure of rat CPR shows the backbone carbonyl of the 
conserved glycine, residue 141, is already pointed directly at the N5H of oxidized 
flavodoxin in the trans O-up conformation (the phi-psi angles are 77, -110), suggesting 
that loop flipping may not be necessary for stabilizing the reduced flavin cofactor (figure 
15). Residue 141 exists in a region of Ramachandran space normally only occupied by 
glycine, thus it is plausible that the G141T mutation will cause a conformational change 
in the FMN binding loop with the oxidized flavin to move threonine 141 into an allowed 
region of Ramachandran space, equivalent to the cis O-down conformation in C. 
beijerinckii.  This would make loop flipping relevant for stabilization of the reduced 
flavin cofactor, much in the same manner as for the C. beijerinckii flavodoxin.  However, 
without crystal structures of the mutant and reduced forms of the enzyme, such 
propositions are purely speculative (figure 39). 
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Ramachandran Plot for WT and G57T Clostridium beijerinckii  flavodoxin
Phi



















Figure 39:  Ramachandran plot of the conserved glycine residue (G57) in the FMN binding 
loop of wild type and G57T mutant C. beijerinckii flavodoxin at various redox states.  The 
position of the conserved glycine residue (G141) in the FMN binding loop of CPR is 
marked with a star. 
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The rather surprising inversion of the relative stabilities of the flavin led us to 
study the electron-transferring activities and mechanistic implications of the G141T 
mutation.  The G141T point mutation decreased the steady-state turnover rate of CPR by 
30%.  The G141T mutation was designed with the intention of disrupting a hydrogen 
bonding interaction between the N5H of the reduced flavin and the main chain carbonyl 
of residue 141, not completely eliminating it.  While the glycine replacement did alter 
substantially the midpoint potential of the OX/SQ couple, these changes were not 
expected to eliminate or greatly reduce the steady-state turnover activity of CPR because 
the potentials are still low enough to reduce cytochrome c.  So, as was expected, the 
glycine to threonine replacement did not inactivate the enzyme or even change the 
activity by orders of magnitude.  However, we believe that the results are significant in 
that this single amino acid replacement did influence the overall cytochrome c reductase 
activity. It is also important to note, that the electron transfer mechanism is complex, 
involving multiple steps. It is a well established observation in enzymology that 
mutations can significantly alter the reaction rate on one step of the enzymatic 
mechanism without having a substantial impact on the overall steady-state turnover rate if 
that step is not rate-limiting overall. Thus, that we saw any effect on the activity of the 
G141T CPR is intriguing. 
The focus of the research turned to providing more direct evidence for the effect 
of the mutation on electron transfer involving the FMN domain using pre-steady state 
experimental approaches.  The mutation was observed to affect the rates of electron 
transfer involving non-physiological chemical reductant (sodium dithionite) and oxidant 
(potassium ferricyanide).  Stopped-flow kinetic studies with the chemical reductant 
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sodium dithionite demonstrated that the SQ-HQ transition in G141T FBD occurs 10 
times faster than in wild type FBD (6.6 s-1 compared to 0.55 s-1).  Not only was the 
reduction of G141T FBD faster than wild type, but so was the oxidation with the 
chemical oxidant potassium ferricyanide.  Stopped flow kinetic studies where fully 
reduced FBD was mixed against a 20-fold excess of potassium ferricyanide showed that 
G141T FBD was oxidized with a rate of approximately 26 s-1 compared to a rate of 
approximately 7 s-1 for wild type FBD.  While these rates clearly demonstrate that the 
G141T mutation affects electron transfer rates, the use of chemical reductants/oxidants 
precludes direct comparison of these results to the steady-state turnover data. 
Pre-steady state approaches were also applied in the study of electron transfer to 
cytochrome c, an established experimental surrogate “physiological” electron acceptor 
for cytochrome P450s.  While several experimental challenges were encountered, many 
of which are inherent to the CPR enzyme itself, some important preliminary observations 
were made. One of the main arguments for the FMN SQ serving as the primary electron 
donor to cytochrome c is that wild type CPR is incapable of forming FMN HQ, either as 
the FAD HQ - FMN HQ or the FAD OX – FMN HQ species in a physiologically relevant 
manner.  Mixing wild-type CPR with a 20-fold excess of NADPH leads to the formation 
of first the disemiquinoide species and then the fully reduced species with rates of 20 s-1 
and 3.5 s-1 respectively [42].  However, steady-state-turnover experiments to cytochrome 
c demonstrate a turnover rate of 65 s-1, demonstrating a disconnect between the pre-
steady-state kinetics and steady-state-turnover data [54].  Additionally, mixing wild type 
CPR with an equimolar solution of NADPH in a stopped-flow spectrophotometer leads to 
the formation of the disemiquinoide species rather than the FAD OX – FMN HQ.  This 
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data led Murataliev et al. argue that the FMN HQ is kinetically incompetent and therefore 
the FMN SQ is the primary electron donor to cytochrome P450s [63]. 
 Surprisingly, the G141T mutant actually increased the rates of electron transfer 
for all measurable steps.  Reduction of G141T CPR by a 15-fold excess of NADPH led to 
the formation of the disemiquinoide species and then the fully reduced species with rates 
of 51 s-1 and 9.5 s-1 respectively, compared to rates of 20 s-1and 3.5 s-1 for wild type CPR.  
The increased rates of electron transfer do not correspond with the steady-state turnover 
data if the FMN SQ is serving as the primary electron donor in G141T CPR.  However, if 
the FMN HQ serves as the primary electron donor for G141T CPR, then the rate-limiting 
step would be 9.5 s-1 compared to 20 s-1 for wild type CPR (figure 40).  This corresponds 
closely with the steady-state turnover data wherein G141T CPR was less than 70% as 
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Figure 40:  A proposed mechanism of electron transfer for the G141T CPR.  The rate-
limiting step for wild type CPR is the transfer of the hydride ion from NADPH to the 
FAD cofactor, which has a rate of 20 s-1. The rate-limiting step for G141T CPR is the 
transition from the disemiquinoide species to the FMN HQ, which has a rate of 9.5 s-1.  
Hence, in wild type, the FMN SQ donates an electron to cytochrome c, while in G141T 
CPR, the FMN HQ donates an electron to cytochrome c. 
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This conclusion would be more substantially supported by the direct measurement 
of the electron transfer rate from the FAD OX – FMN HQ redox species to cytochrome c 
in the stopped flow spectrophotometer.  Unfortunately, our ability to directly measure the 
rates of electron transfer from the FMN HQ in both wild type and G141T CPR has been 
largely precluded because of issues inherent to the enzyme itself.  For example, for the 
wild-type CPR, the four-electron-reduced reductase takes up to 8 hours of incubation 
under anaerobic conditions in the presence of NADPH and the NADPH regenerating 
system to form [41].  This is most likely due to an equilibration reaction of CPR and 
NADPH wherein the air-stable inactive FMN is kinetically stabilized upon conformation 
drifting [32, 45].  Similar to wild type CPR, G141T CPR was incapable of forming the 
four-electron-reduced reductase, but since this observation is the result of kinetic 
stabilization of the inactive, air-stable semiquinone rather than the midpoint potentials of 
the flavins themselves, this result is not terribly surprising.  Our attempts to measure the 
rate of cytochrome c reduction by G141T CPR which had been fully reduced chemically 
by sodium dithionite in the presence of NADP+ were compromised because of the ability 
of the reduced reductase to partially reduce NADP+ to NADPH by analogy to ferredoxin-
NADP+ reductase, its homologue.  Even then, no discernable reduction of cytochrome c 
was observed.  The rates of electron transfer to cytochrome c from the G141T FBD (the 
isolated FMN-binding domain itself) fully reduced by dithionite was experimentally more 
tractable, but the transfer rates were observed to be very slow, well outside the steady-
state turnover rates.  We were able to obtain electron transfer rates by single-turnover 
experiments when the oxidized CPR (wild type and mutant) were rapidly mixed with 
oxidized cytochrome c containing varying concentrations of NADPH.  Electron transfer 
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to cytochrome c was observed with a Kmax of 7.9 s-1 determined for the G141T CPR and 
Kmax of 4.55 s-1 obtained for wild type CPR under similar conditions. The relative rates, 
while different by about two-fold, are inconsistent with the steady-state-turnover data, 
however, where the steady-state rate for the mutant is slower than wild type.   
 While frustrating, these results are consistent with the general observations in the 
field regarding the interrelationships of pyridine nucleotide binding, the potential 
influence of the FAD-binding domain on the electron transfer steps involving the FMN-
binding domain, and the nature of the formation of the electron-transfer complex with 
cytochrome c itself.  For example, Grunua et al. indicate that interaction between 
NADPH/NADP+ and CPR is necessary for the FMN binding domain to overcome its 
constrained state and efficiently interact with cytochrome c [32].  Through the use of 
isothermal titration calorimetry studies, Grunua et al. demonstrated that for the isolated 
FBD to interact with cytochrome c, the FMN cofactor must be reduced to the 
semiquinone state by sodium dithionite.  However, when the FMN cofactor of the intact 
reductase is reduced by sodium dithionite to the semiquinone state, there is no interaction 
between CPR and cytochrome c.  Isothermal titration calorimetry studies also 
demonstrated that the number of accessible conformational substates for the FBD 
increase upon binding of NADP+ or 2’,5’ ADP.  These results led Grunua et al. to 
propose that NADPH binding causes a conformational change between the two domains, 
allowing the FBD to overcome a kinetically unproductive conformation [32]. 
 In conclusion, my original goals to demonstrate that glycine 141 in rat CPR plays 
a critical role in stabilizing the reduced forms of the FMN cofactor and to assess the 
effects of this residue on the electron transfer properties of CPR were reached 
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successfully.  It was conclusively demonstrated that glycine residue in CPR contributes to 
the redox properties of the FMN cofactor in CPR in a similar manner to the conserved 
glycine residues in the FMN binding loops of the D. vulgaris and C. beijerinckii 
flavodoxins. Like the flavodoxin, the glycine to threonine replacement substantially 
reduces the stability of the neutral FMN SQ species thereby lowering the midpoint 
potential for the OX/SQ couple.   
Because the neutral FMN SQ has been proposed to be the direct electron donor to 
the cytochrome during catalysis, the glycine to threonine replacement was expected to 
alter the activity of the reductase.  In fact, although the effect was relatively small, a 
lower rate of cytochrome c reduction was observed during steady-state turnover.  The 
stopped-flow pre-steady state kinetic studies demonstrated that the glycine-141 to 
threonine replacement affected the rate of all measurable electron transfer steps; however, 
the rates were higher than for wild type.  Although further experimental proof is needed, 
perhaps most importantly, the evidence suggests that the G141T mutation may well have 
changed the mechanism of electron transfer in CPR from the FMN SQ serving as the 
primary electron donor to cytochrome c to the FMN HQ serving as the primary electron 
donor, although in a catalytically less efficient manner.  Thus, glycine-141 has been 
conserved in the FMN binding loop to maintain catalytic efficiency and to preserve the 
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